KR101723588B1 - Composition for mouth comprising camellia japonica l leaf extract and manufacturing method thereof - Google Patents

Composition for mouth comprising camellia japonica l leaf extract and manufacturing method thereof Download PDF

Info

Publication number
KR101723588B1
KR101723588B1 KR1020150010837A KR20150010837A KR101723588B1 KR 101723588 B1 KR101723588 B1 KR 101723588B1 KR 1020150010837 A KR1020150010837 A KR 1020150010837A KR 20150010837 A KR20150010837 A KR 20150010837A KR 101723588 B1 KR101723588 B1 KR 101723588B1
Authority
KR
South Korea
Prior art keywords
weight
composition
extract
oral
camellia
Prior art date
Application number
KR1020150010837A
Other languages
Korean (ko)
Other versions
KR20160090708A (en
Inventor
김수관
이숙영
Original Assignee
조선대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 조선대학교산학협력단 filed Critical 조선대학교산학협력단
Priority to KR1020150010837A priority Critical patent/KR101723588B1/en
Priority to PCT/KR2016/000633 priority patent/WO2016117933A1/en
Priority to CN201680016936.0A priority patent/CN107427454B/en
Publication of KR20160090708A publication Critical patent/KR20160090708A/en
Application granted granted Critical
Publication of KR101723588B1 publication Critical patent/KR101723588B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • A61K8/21Fluorides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Abstract

본 발명은 동백나무 잎으로부터 추출된 추출물을 포함하는 구강용 조성물 및 그 제조방법에 관한 것으로서, 본 발명의 구강용 조성물은 항산화 효과, 항미생물 효과, 및 구강 암세포 증식억제효과 중 적어도 하나를 나타낸다.The present invention relates to an oral composition containing an extract extracted from a camellia leaf and a method of preparing the same, wherein the oral composition of the present invention exhibits at least one of an antioxidative effect, an antimicrobial effect, and an oral cancer cell proliferation inhibitory effect.

Description

동백잎 추출물을 포함하는 구강용 조성물 및 그 제조방법{COMPOSITION FOR MOUTH COMPRISING CAMELLIA JAPONICA L LEAF EXTRACT AND MANUFACTURING METHOD THEREOF}TECHNICAL FIELD The present invention relates to a composition for oral cavity including a camellia leaf extract, and a method for producing the same. BACKGROUND ART [0002]

본 발명은 동백잎 추출물을 포함하는 구강용 조성물 및 그 제조방법에 관한 것이다.The present invention relates to an oral composition comprising a camphor leaf extract, and a method for producing the same.

구강질환은 우리나라 성인의 80%가 앓고 있으며, 60대 이상 노령 인구의 약 90%가 앓고 있는 만성질환이다. 잇몸질환이 외래 다빈도 질환 중에서 3위를 차지하고 있으며, 발병률이 높고 매년 증가추세로 보고되고 있다.Oral diseases are 80% of adults in Korea and about 90% of elderly people over 60 are suffering from chronic diseases. Gingival disease is the third most common foreign disease, and its incidence is high and it is reported to increase every year.

치주질환은 전신만성질환 발생과 밀접한 관련이 있다. 의료 및 치의약 분야 관련 건강보조식품과 위생용품 개발시, 친환경 및 인체친화적 천연소재의 중요성은 날로 증대되고 있으며, 특히, 전신만성질환 발생과 밀접한 관련이 있는 치주질환 예방과 개선을 위한 구강보건용품 소재에서 phyto-material에 대한 관심이 증가하고 있다.Periodontal disease is closely related to the occurrence of systemic chronic diseases. The importance of eco-friendly and human-friendly natural materials is increasing day by day in the development of health supplements and hygiene products related to the medical and dental medicine fields. Especially, in order to prevent and improve periodontal diseases, Interest in phyto-materials is increasing in the materials.

국내 성인의 80%, 그리고 실버세대 연령의 90%가 만성적으로 구강질환에 시달리고 있으나 사전에 예방차원에서 관리할 수 있는 보조제품의 개발 및 상용화가 이루어지지 않고 있다.Although 80% of domestic adults and 90% of the silver generation age are suffering from chronic oral diseases, the development and commercialization of auxiliary products that can be managed in advance preventive measures have not been made.

현재 판매중인 기능성 세치제의 경우, 프라그 저해, 구강내 유해균 억제, 구취개선, 미백효과 등의 기능성이 부가되어 있으나 연령별, 개인의 구강체질별 특성을 감안하지 않은 제품들이 대다수로 사용시 잇몸질환과 구내염증을 오히려 악화시키는 경우가 빈번하게 발생하고 있어 이를 대체할 제품개발 기술이 요구되고 있다.Functional detergents currently on the market include functional inhibition of plaque inhibition, inhibition of noxious bacteria in oral cavity, improvement of bad breath, and whitening effect. However, most products that do not take into account age, Inflammation is often exacerbated, and there is a demand for a product development technology to replace it.

종래 동백나무과 식물의 잎을 주재료로 하는 치약 조성물이 한국 특허 제제10-1391545호(발명의 명칭: 한방추출물과 프로폴리스가 첨가된 치약)에 개시되어 있었다. 이때 여기에 개시된 동백나무과 식물이 동백나무 잎을 지칭하는 게 아니며, 식물분류학적으로 동백나무과 식물에 속하는 식물종은 무려 1000종이나 되므로 본 발명에서 재료로 하는 동백나무 잎은 1,000종 중의 한 종에 해당될 뿐 제 10-1391546에 개시되어있는 동백나무과 식물이 반드시 동백나무 잎을 지칭한다고 볼 수 없다.A dentifrice composition comprising a camellia plant leaf as a main ingredient has been disclosed in Korean Patent No. 10-1391545 (entitled "Oriental herb extract and propolis-added toothpaste"). In this case, the camellia plant disclosed herein does not refer to camellia leaves. Since the number of plant species belonging to Camellia crassifolia is about 1,000, the camellia leaves used as a material in the present invention is one of 1,000 species It can not be said that the camelliace plants disclosed in the Japanese Patent Application No. 10-1391546 necessarily refer to the camellia leaves.

그러나 종래의 치약은 치주질환 및 각종 구강질환의 치료를 목적으로 동백나무과 식물의 잎에서 추출한 추출물을 함유하거나 각종 식물잎이나 꽃잎등의 추출물이 사용되고 있으나 이 경우, 각종 구강질환의 치료 및 예방의 효과는 있지만 치약을 장기간 사용 시 치약 조성물의 색상이 변질되거나 향이 변화되면서 치약 조성물에 함유된 약효제의 효과가 감소되고 사용 시 불쾌감을 유발하는 등 치약의 상품성이 떨어지는 문제점이 있었다.However, conventional toothpastes contain extracts extracted from leaves of Camellia crassifolia and various plant leaves or petals for the purpose of treatment of periodontal diseases and various oral diseases, but in this case, effects of treatment and prevention of various oral diseases , There is a problem that the dentifrice composition is deteriorated in color or the flavor is changed when the dentifrice is used for a long period of time, the effect of the medicinal effect contained in the dentifrice composition is reduced and the commercial properties of the dentifrice causing discomfort during use are decreased.

본 발명은 동백나무 잎으로부터 추출한 추출물을 이용한 저자극, 기능성 천연소재 구강용 조성물 및 그 제공방법을 제공하는 것을 목적으로 한다.The present invention aims to provide a composition for a low-irritation and functional natural-type oral cavity using the extract extracted from camellia leaves and a method for providing the same.

본 발명은 변질과 향변화를 억제하는 항산화력과 배초향 유래 정유성분이 추가되므로서 치약의 색상이 유지되고 향이 변화되더라도 치약에 함유된 약효제의 효과가 유지되고 사용 시 상쾌함을 주는 구강용 조성물 및 그 제조방법을 제공한다. The present invention relates to a composition for oral cavity which maintains the effect of a pharmacologically active agent contained in toothpaste and maintains the effect of the pharmacological effect contained in the toothpaste even when the color of toothpaste is maintained and the flavor thereof is changed by adding antioxidant power for inhibiting deterioration and flavor change and essential oil- And a manufacturing method thereof.

일 실시예에서, 본 발명은 동백나무 잎으로부터 추출한 추출물을 포함하는 구강용 조성물을 제공한다.In one embodiment, the present invention provides an oral composition comprising an extract from camellia leaves.

다른 실시예에서, 본 발명은 동백나무 잎으로부터 추출한 추출물 1~4중량%, 배초향 추출물 0.001~0.010중량%, 산수유 추출물 0.001~0.010중량%, 인동초 추출물 0.001~0.010중량%, 상엽추출물 0.20~0.80중량%를 포함하는 구강용 조성물을 제공한다. In another embodiment, the present invention relates to a method for the treatment and / or prophylaxis of cancer, comprising 1 to 4% by weight of an extract from camellia leaves, 0.001 to 0.010% by weight of a pine needle extract, 0.001 to 0.010% by weight of an extract of corn oil, 0.001 to 0.010% % ≪ / RTI > by weight of the composition.

이때 구강용 조성물은 효소처리 스테비아 0.25~0.50중량%, 자일리톨 0.10~0.50중량%, D-소르비톨액 40~60중량%, 덴탈타입실리카 15중량%, 플루오르화나트륨 0.22중량%, 피리독신염산염 0.05중량%, 피로인산나트륨 0.50중량%, 식물성 글리세린 2~3중량%, 하이드록시 아파타이트 0.05중량%, 정제수 12.58~30중량%를 추가로 포함할 수 있다. At this time, the composition for oral use was 0.25 to 0.50% by weight of enzyme-treated Stevia, 0.10 to 0.50% by weight of xylitol, 40 to 60% by weight of D-sorbitol solution, 15% by weight of dental type silica, 0.22% by weight of sodium fluoride, 0.05% by weight of pyridoxine hydrochloride, 0.50% by weight of sodium pyrophosphate, 2 to 3% by weight of vegetable glycerin, 0.05% by weight of hydroxyapatite, and 12.58 to 30% by weight of purified water.

또 다른 실시예에서, 본 발명은 동백나무 잎으로부터 추출한 추출물 1~4중량%, 배초향 정유(essential oil) 0.001~0.010중량%, 산수유 추출물 0.001~0.010중량%, 인동초 추출물 0.001~0.010중량%, 상엽추출물 0.20~0.80중량%를 용제에 첨가하는 단계; 및 효소처리 스테비아 0.25~0.50중량%, 자일리톨 0.10~0.50중량%, D-소르비톨액 40~60중량%, 덴탈타입실리카 15중량%, 플루오르화나트륨 0.22중량%, 피리독신염산염 0.05중량%, 피로인산나트륨 0.50중량%, 식물성 글리세린 2~3중량%, 하이드록시 아파타이트 0.05중량%, 정제수 12.58~30중량%를 상기 용제에 첨가하는 단계를 포함하는, 구강용 조성물 제조방법을 제공한다. In yet another embodiment, the present invention provides a composition comprising 1 to 4% by weight of an extract from camellia leaves, 0.001 to 0.010% by weight of essential oil, 0.001 to 0.010% by weight of an extract of corn oil, 0.001 to 0.010% Adding 0.20 to 0.80% by weight of the extract to the solvent; And 0.1 to 0.50% by weight of enzyme treated stevia, 0.10 to 0.50% by weight of xylitol, 40 to 60% by weight of D-sorbitol solution, 15% by weight of dental type silica, 0.22% by weight of sodium fluoride, 0.05% by weight of pyridoxine hydrochloride, 0.5 to 0.50% by weight of vegetable glycerin, 2 to 3% by weight of vegetable glycerin, 0.05% by weight of hydroxyapatite and 12.58 to 30% by weight of purified water to the solvent.

상기에서 사용된 동백나무는 식물분류학적으로 동백나무과 동백나무속 동백나무(Camellia japonica L)를 지칭한다. The camellia used in the above refers to camellias and Camellia japonica L as a plant taxonomic.

본 발명의 조성물은 치은염 개선, 항산화활성, 구강유해균의 억제 및 살균성, 치석개선능을 나타낸다.The composition of the present invention shows improvement of gingivitis, antioxidative activity, suppression of oral pest, bactericidal action, and dental calculus improving ability.

또한 발명의 조성물은 구강보건 유지에 유효한 동백나무 잎으로부터 추출된 추출물을 함유하므로서 잇몸염증를 치유하고, 치아우식증과 잇몸노화 예방 및 치석침착을 예방하는 효과가 있다.In addition, the composition of the present invention contains an extract extracted from camellia leaves, which is effective for oral health maintenance, to heal gum inflammation, prevent dental caries, prevent gum aging, and prevent dental deposition.

또한 본 발명의 조성물은 변질과 향변화를 억제하는 항산화력과 배초향 유래 정유성분이 추가되므로서 치약의 색상이 유지되고 향이 변화되더라도 치약에 함유된 약효제의 효과가 유지되고 사용 시 상쾌함을 주는 효과가 있다. In addition, the composition of the present invention has antioxidant ability which suppresses alteration and fragrance change and essential oil-derived essential oil component, so that even if the color of the toothpaste is maintained and the flavor is changed, the effect of the pharmacologically active agent contained in the toothpaste is maintained, .

도 1은 각 월에 따른 동백잎의 에탄올 추출물의 페놀 함량(Total phenolic contents of ethanol extracts from each month of Camellia japonica L. leaves)을 나타내고 있다.
도 2는 각 월에 따른 동백잎의 에탄올 추출물의 DPPH radical 소거능(DPPH radical scavenging activity of ethanol extracts from each month of Camellia japonica leaves)을 나타내고 있다.
도 3은 동백잎 효소추출물의 catalase 활성(Catalase activities of extracts from each part of camellia)을 나타내고 있다.
도 4는 충치 유발균 S. mutans에 대한 동백나무 잎으로부터 추출된 추출물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL, ④ 100mg/mL)을 나타낸다.
도 5는 치아우식 유발균 S. sobrinus에 대한 동백나무 잎으로부터 추출된 추출물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL, ④ 100mg/mL)을 나타낸다.
도 6은 구내염의 원인균 C. albicans에 대한 동백나무 잎으로부터 추출된 추출물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL, ④ 100mg/mL)을 나타낸다.
도 7은 충치 유발균 S. mutans에 대한 세치제 조성물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL(1mm), ④ 100mg/mL(3mm))을 나타낸다.
도 8은 치아우식 유발균 S. sobrinus에 대한 세치제 조성물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL, ④ 100mg/mL)을 나타낸다.
도 9은 구내염의 원인균 C. albicans에 대한 세치제 조성물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL, ④ 100mg/mL)을 나타낸다.
도 10은 동백잎의 에탄올 추출물의 DPPH radical 소거능(DPPH radical scavenging activity of ethanol extracts from Cornus officinalis)을 나타내고 있다.
도 11은 산수유 추출물의 SOD 활성(HL/F; 산수유 열매)을 나타내고 있다.
도 12는 배초향 정유(essential oil)의 항산화 활성(Antioxidant activity of extracts from Agastache rugosa)을 나타내고 있다.
도 13은 배초향 정유(essential oil)의 항미생물 활성(Antimicrobial activity of essential oil from herb against Staphylococcus epidermidis. ① 배초향 꽃 ② 배초향 지상부)을 나타내고 있다.
도 14는 배초향 정유(essential oil)의 농도에 따른 항미생물 활성(Antimicrobial activity of essential oil depending on various concentration against Staphylococcus epidermidis. A 배초향꽃, B 배초향 지상부)을 나타내고 있다.
도 15는 배초향 정유(essential oil)의 항미생물 활성(Antimicrobial activity of essential oil from herb against Propionibacterium acnes. 1. 배초향 꽃 2. 배초향 지상부)을 나타내고 있다.
도 16은 배초향 정유(essential oil)의 농도에 따른 항미생물 활성(Antimicrobial activity of essential oil depending on various concentration against Propionibacterium acnes)을 나타내고 있다.
도 17은 배초향 정유(essential oil)의 항미생물 활성(Antimicrobial activity of essential oil from herb against Malassezia furfur. 좌측: 배초향 꽃 우측: 배초향 지상부)을 나타내고 있다.
도 18은 상엽 추출물(좌측)과 상백피 추출물(우측)의 항균활성 결과를 나타내고 있다.
FIG. 1 shows the phenolic contents of ethanol extracts from Camellia japonica L. leaves in each month.
FIG. 2 shows DPPH radical scavenging activity of ethanol extracts from Camellia japonica leaves of ethanol extract of camellia leaves according to each month.
FIG. 3 shows the catalase activities of extracts of Camellia sinensis from various parts of camellia.
Fig. 4 shows the antimicrobial activity (① 20 mg / mL, ② 40 mg / mL, ③ 80 mg / mL, and ④ 100 mg / mL) of the extract extracted from camellia leaves against the carotid bacterium S. mutans.
Fig. 5 shows the antimicrobial activity (① 20 mg / mL, ② 40 mg / mL, ③ 80 mg / mL, and ④ 100 mg / mL) of the extract extracted from camellia leaves against dental caries-inducing S. sobrinus.
Figure 6 shows the antimicrobial activity of extracts from camellia leaves against the causative organism C. albicans (20 mg / mL, 40 mg / mL, 80 mg / mL, and 100 mg / mL).
Fig. 7 shows the antimicrobial activity (① 20 mg / mL, ② 40 mg / mL, ③ 80 mg / mL (1 mm), and 100 mg / mL (3 mm)) of the anticancer composition against the cavity-inducing S. mutans.
Fig. 8 shows the antimicrobial activity (① 20 mg / mL, ② 40 mg / mL, ③ 80 mg / mL, and ④ 100 mg / mL) of a cicatricial composition against dental caries-inducing S. sobrinus.
Fig. 9 shows the antimicrobial activity (① 20 mg / mL, ② 40 mg / mL, ③ 80 mg / mL, and ④ 100 mg / mL) of the anticancer composition against C. albicans causing the stomatitis.
FIG. 10 shows DPPH radical scavenging activity of ethanol extracts from Cornus officinalis of ethanol extract of camellia leaves.
Fig. 11 shows the SOD activity (HL / F) of the extract of corn oil.
Fig. 12 shows the antioxidant activity of extract oil from Agastache rugosa.
Figure 13 shows the antimicrobial activity of essential oil from the essential oil of herb against Staphylococcus epidermidis.
FIG. 14 shows the antimicrobial activity of essential oil depending on the concentration of essential oil. FIG. 14 shows the antimicrobial activity of essential oil depending on the concentration of essential oil in the staphylococcus epidermidis.
FIG. 15 shows the antimicrobial activity of essential oil from herb against Propionibacterium acnes (1).
FIG. 16 shows the antimicrobial activity of essential oil depending on the concentration of essential oil.
FIG. 17 shows the antimicrobial activity of essential oil from herbicide of Malassezia furfur.
Fig. 18 shows the results of antimicrobial activity of the extracts of the upper leaves (left side) and the extract of the mulberry bark (right side).

이하, 본 발명의 일부 실시예들을 예시적인 도면을 통해 상세하게 설명한다. 각 도면의 구성요소들에 참조부호를 부가함에 있어서, 동일한 구성요소들에 대해서는 비록 다른 도면상에 표시되더라도 가능한 한 동일한 부호를 가지도록 하고 있음에 유의해야 한다. 또한, 본 발명을 설명함에 있어, 관련된 공지 구성 또는 기능에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우에는 그 상세한 설명은 생략한다.Hereinafter, some embodiments of the present invention will be described in detail with reference to exemplary drawings. It should be noted that, in adding reference numerals to the constituent elements of the drawings, the same constituent elements are denoted by the same reference numerals even though they are shown in different drawings. In the following description of the present invention, a detailed description of known functions and configurations incorporated herein will be omitted when it may make the subject matter of the present invention rather unclear.

본 명세서에서 %는 별도의 언급이 없는 경우에 부피%이나 필요에 따라서 중량%일 수 있다.In the present specification, the percentages may be% by volume or, if necessary,% by weight, unless otherwise specified.

본 발명은 동백나무를 이용한 구강청결 및 구취개선, 구내유해균 억제효능이 있는 구강용 조성물 및 그 치약, 그 제조방법을 제공한다. 이 구강용 조성물은 세치제(치약) 조성물, 구강세정제 조성물, 구강향수 조성물, 의치세정제 조성물, 이쑤시게 코팅용 조성물, 치실 코팅용 조성물, 구강용 필름 조성물, 잇몸 보호용 젤 조성물, 기타 구강보건을 위한 조성물로 사용될 수 있다.The present invention provides an oral composition for oral hygiene and improvement of oral hygiene, an effect of inhibiting harmful bacteria in the oral cavity, a dentifrice thereof, and a preparation method thereof. The composition for oral use may be selected from the group consisting of a toothpaste composition, a mouthwash composition, an oral perfume composition, a dentifrice composition, a toothpick coating composition, a composition for dental coating, a mouth film composition, .

구강은 다양한 미생물이 서식하는데 매우 용이한 환경을 제공함으로써 병원성 감염균주 및 상주균 등에 의한 구강질환 및 전신질환의 중요한 원인 중 하나로 여겨져 왔다. 이러한 구강 내 미생물의 생육조건을 조절함으로써 구강보건을 향상시키려는 방법이 다양하게 연구되고 개발되어 왔으나 최근 약물의 오용 및 남용과 원내 감염균에 대한 약제내성이 심각한 문제로 대두되면서 새로운 대체약물의 필요성이 대두되고 있다. Oral has been considered as one of the important causes of oral and systemic diseases caused by pathogenic infectious strains and resident bacteria by providing a very easy environment for various microorganisms. In order to improve oral health by controlling the growth conditions of oral microorganisms, various researches and developments have been made. However, since the abuse and abuse of medicines and the resistance of medicines to the infectious organisms have become serious problems, .

이하 동백나무 잎으로부터 추출된 추출물을 포함하는 구강용 조성물의 제조방법 및 그 조성물을 구체 예를 통하여 상세히 설명하지만, 본 발명의 범위가 이러한 구체 예에 의해 제한되는 것은 아님을 명심하여야 한다.Hereinafter, a method for producing an oral composition including an extract derived from camellia leaves and a composition thereof will be described in detail by way of specific examples, but it should be borne in mind that the scope of the present invention is not limited by these embodiments.

본 발명은 구강보건 유지에 유효한 동백나무 잎으로부터 추출된 추출물을 주요 기능소재로 하고, 배초향 정유(essential oil), 산수유 추출물, 인동초 추출물, 상엽 추출물을 부 기능소재로 함유하므로서 잇몸염증를 치유하고, 치아우식증과 잇몸노화 예방 및 치석침착을 예방하는 세치제 조성물과 그 제조방법에 관한 것으로, 특히 치은염 개선, 항산화활성, 구강유해균의 억제 및 살균, 치석개선능을 가지고 있는 동백나무 잎으로부터 추출된 추출물을 주요 기능소재로 첨가하므로서 치은염 및 기타 구강질환을 예방하고 개선할 수 있는 구강용 조성물 및 그 제조방법에 관한 것이다. The present invention relates to a method for treating gum inflammation by containing an extract extracted from a camellia leaf which is effective for oral health maintenance and containing essential oil, essential oil, corn oil extract, The present invention relates to a composition for preventing dental caries, preventing premature aging of teeth and dental calculus, and a method of manufacturing the same, and particularly relates to a composition for improving gingivitis, antioxidant activity, inhibition and sterilization of oral noxious bacteria, To a composition for oral cavity which can prevent and improve gingivitis and other oral diseases by adding it as a main functional material, and a method for producing the same.

또한, 본 발명 조성물은 유아들과 고령자의 취약한 구강상태를 고려한 저자극 천연소재를 중심으로 구성된 세치제로 될 수 있다. In addition, the composition of the present invention can be a detergent composed mainly of a low-stimulus natural material considering vulnerable oral conditions of infants and the elderly.

상기 목적을 달성하기 위한 본 발명의 동백나무 잎으로부터 추출된 추출물을 주요 소재로 한 세치제 조성물은, 동백나무 잎으로부터 추출된 추출물 1~4중량%, 배초향 정유(essential oil) 0.001~0.010중량%, 산수유 추출물 0.001~0.010중량%, 인동초 추출물 0.001~0.010중량%, 상엽추출물 0.20~0.80중량%, 효소처리 스테비아 0.25~0.50중량%, 자일리톨 0.10~0.50중량%, D-소르비톨액 40~60중량%, 덴탈타입실리카 15중량%, 플루오르화나트륨 0.22중량%, 피리독신염산염 0.05중량%, 피로인산나트륨 0.50중량%, 식물성 글리세린 2~3중량%, 하이드록시 아파타이트 0.05중량%, 정제수 12.58~30중량%를 혼합 조성한 것을 특징으로 한다.In order to accomplish the above object, the present invention provides a detergent composition comprising as an essential ingredient an extract extracted from camellia leaves, comprising 1 to 4% by weight of an extract derived from a camellia plant leaf, 0.001 to 0.010% by weight of essential oil, 0.001 to 0.010% by weight of the extract of corn oil, 0.001 to 0.010% by weight of the extract of Oriental herbal extract, 0.20 to 0.80% by weight of the leaf extract, 0.25 to 0.50% by weight of the enzyme-treated stevia, 0.10 to 0.50% by weight of xylitol, 15 wt% of dental type silica, 0.22 wt% of sodium fluoride, 0.05 wt% of pyridoxine hydrochloride, 0.50 wt% of sodium pyrophosphate, 2 to 3 wt% of vegetable glycerin, 0.05 wt% of hydroxyapatite, and 12.58 to 30 wt% of purified water And then mixed.

이때 동백나무 잎으로부터 추출된 추출물, 배초향 정유(essential oil), 산수유 추출물, 인동초 추출물, 상엽 추출물은 주정 알콜로 추출한 농축액이다. The extracts from Camellia sinensis leaf, essential oil, Sansori oil extract, Rhizoctonia soluum extract, and Mulberry leaf extract were concentrated alcohol extracted with alcohol.

본 발명의 동백나무 잎으로부터 추출된 추출물을 주요 소재로 한 세치제 조성물의 제조방법은, 진공의 원리를 적용하여 혼합물내의 기포제거가 가능한 멀티믹서(LAB-NEO-V)를 사용하며, 천연물인 동백나무 잎으로부터 추출된 추출물 1~4중량%, 배초향 정유(essential oil) 0.001~0.010중량%, 산수유 추출물 0.001~0.010중량%, 인동초 추출물 0.001~0.010중량%, 상엽추출물 0.20~0.80중량%를 믹서의 포트에 첨가하기 전에 미리 정제수와 함께 혼합하여 50℃의 조건에서 소니케이터(JAC-4020)로 완전하게 현탁 용해시키는 1차 혼합단계, 멀티믹서 jar내에 덴탈타입실리카 15중량%, 플루오르화나트륨 0.22중량%, 피로인산나트륨 0.50중량%, 하이드록시 아파타이트 0.05중량%를 각각 투여하여 정제수와 함께 상온에서 20분간 균일하게 혼합하는 2차 혼합단계, 2차 혼합단계의 혼합액에 효소처리 스테비아 0.25~0.50중량%, 자일리톨 0.10~0.50중량%, D-소르비톨액 40~60중량%, 식물성 글리세린 2~3중량%를 첨가하여 50℃의 조건에서 20분간 균일하게 혼합하는 3차 혼합단계, 2차 혼합단계 및 3차 혼합단계에 따른 혼합액에 1차 혼합단계에서 혼합한 천연물를 추가하여 50℃의 조건에서 30분간 균일하게 혼합하는 4차 혼합단계, 마지막으로 상온에서 10분간 혼합한 후 10-3 Torr의 조건의 진공상태에서 기포를 제거하는 마무리 단계를 포함한다. The method for preparing a detergent composition using the extract extracted from the camellia leaves of the present invention is characterized by using a multi-mixer (LAB-NEO-V) capable of removing bubbles in the mixture by applying the principle of vacuum, 0.001 to 0.010% by weight of an essential oil, 0.001 to 0.010% by weight of an extract of corn oil, 0.001 to 0.010% by weight of an extract of Oriental herb extract, and 0.20 to 0.80% (JAC-4020) under the condition of 50 캜 before mixing with the purified water before adding to the pot of the mixer jar, 15% by weight of dental type silica in the multi-mixer jar, 15% by weight of sodium fluoride 0.22% by weight of sodium pyrophosphate, 0.50% by weight of sodium pyrophosphate, and 0.05% by weight of hydroxyapatite, and then mixed with the purified water for 20 minutes at room temperature. A third mixing step of adding 0.25 to 0.50 wt% of stevia, 0.10 to 0.50 wt% of xylitol, 40 to 60 wt% of D-sorbitol solution and 2 to 3 wt% of vegetable glycerin and uniformly mixing them at 50 캜 for 20 minutes, second mixing step and the fourth mixing stage for mixing the 30 minutes at the conditions of 50 ℃ uniform in addition to the tertiary mixture in accordance with the mixing step cheonyeonmulreul mixed in a primary mixing stage, and then finally mixed for 10 minutes at room temperature 10 - And a finishing step of removing air bubbles under a vacuum of 3 Torr.

이하에서 동백나무 잎으로부터 추출된 추출물, 배초향 정유(essential oil), 인동초 추출물, 상엽 추출물의 특성 및 효능을 살펴본다.The properties and efficacy of extracts from Camellia sinensis, essential oil, Rhizoctonia solanum L., and Mulberry leaf extract are examined below.

I. 구강용 조성물의 주요 성분I. Main Ingredients of Oral Compositions

동백나무 잎으로부터 추출된 추출물Extracts from camellia leaves

동백나무(Camellia japonica L)는 식물분류학적으로 동백나무과 동백나무속에 속하는 상록교목으로 우리나라의 온대 남부의 해안 도서인 고창, 완도, 강진, 나주, 여수 등의 전남지역을 중심으로 충남, 제주지역에 자생식재되어 있으며, 특히 전남지역이 전국 식재 면적의 67%를 차지하고 있다. 최근의 보고된 연구 결과에 의하면 동백엽과 과피 등도 항원충작용 및 진경작용, 치석형성 억제효과, 알콜 흡수 억제, 미백 작용, 소염작용과 HIV-1 protease 억제활성 등과 같은 약리활성이 있고, 이러한 생리활성이 있는 잎 부위는 한국과 일본 등지에서 예로부터 어린 엽을 차의 재료로 사용하기도 하였다. 동백나무에 함유되어 있는 주요 성분으로는 꽃에는 leucoanthocyanin, anthocyanin 등이 함유되어 있으며 과실에는 지방유, camellin, tsubaki-saponin 및 tsubaki-saponin의 aglycon인 camelliagenin ABC가 함유되어 있고 잎에는 ι-epicatechol, d-catechol 등이 함유되어 있다. 이상과 같이 동백은 주요 약효성분을 다량 함유하고 있고 생리약리활성이 다양하지만, 부위별로 이를 식용화 및 2차 가공제품으로 산업화하기 위한 연구는 수행되고 있지 않아 아쉬운 실정이다.Camellia japonica L (Camellia japonica L) is an evergreen tree belonging to Camellia japonica and Camellia japonica. It is a species of Camellia japonica L. It is located in Jeolla province such as Gochang, Wando, Kangjin, Naju and Yeosu And Jeonnam region occupies 67% of the total planted area. According to recent reported results, there are pharmacological activities such as antioxidant action and antioxidant activity, inhibition of tartar formation, inhibition of alcohol absorption, whitening action, anti-inflammatory action and HIV-1 protease inhibitory activity, The active leaves have been used for long time in Korea and Japan. The main components contained in camellia include flowers such as leucoanthocyanin and anthocyanin. The fruit contains camelliagenin ABC, which is an aglycon of fatty oil, camellin, tsubaki-saponin and tsubaki-saponin. The leaves contain ι-epicatechol, d- catechol and so on. As described above, camellia contains a large amount of major active ingredients, and its physiological activity is various. However, studies for industrializing it into edible products and secondary processed products have not been conducted yet.

전술한 한국 특허 제제10-1391545호(발명의 명칭: 한방추출물과 프로폴리스가 첨가된 치약)에 개시된 동백나무과 식물은 본 발명에서 식물분류학적으로 동백나무과 동백나무속에 속하는 동백나무(Camellia japonica L)과 다르다. 즉 식물분류학적으로 동백나무과 식물에 속하는 식물종은 무려 1000종이나 되므로 본 발명에서 재료로 하는 동백나무 잎은 1,000종 중의 한 종에 해당될 뿐 한국 특허 제 10-1391546에 개시되어있는 동백나무과 식물이 반드시 본 발명에서 식물분류학적으로 동백나무과 동백나무속에 속하는 동백나무(Camellia japonica L)를 지칭한다고 볼 수 없다.The Camellia japonica L belonging to Camellia and Camellia is a plant taxonomically disclosed in Korean Patent No. 10-1391545 (entitled "Herbal Extract and Propolis-Added Toothpaste"), . Namely, since the number of plant species belonging to Camellia crassifolia is 1,000, the camellia leaves used as a material in the present invention corresponds to only one of 1,000 species, and the camellia plant family disclosed in Korean Patent No. 10-1391546 (Camellia japonica L) belonging to Camellia and Camellia can not be referred to as plant taxonomically in the present invention.

1. 항미생물 활성 테스트1. Anti-microbial activity test

1) 항균활성 테스트1) Antimicrobial activity test

본 실험에 사용된 동백나무는 전남 장흥군 천관산의 동백자생 군락지에서 자생하고 있는 야생동백나무로부터 꽃은 2~3월에, 어린잎은 4~5월에 그리고 성엽은 6~8월에 각각 채취하여 사용하였다. 항미생물 활성에 사용된 균은 그람양성균으로 Bacillus subtillis, Streptomyces fradiae Staphylococcus aureus를 사용하였고, 그람음성균으로 Escherichia coli, Pseudomonas aeruginosa, Enterobacter spp. C1036 및 Salmonella typhimurium을 각각 사용하였다. 동백의 생엽 시료를 추출에 적합하도록 분말화하여 시료중량 10배의 메탄올을 첨가하고 40℃에서 5~6시간씩 추출한 후, 여과하여 감압농축기를 사용하여 추출용매를 제거한 후 동결건조기를 이용하여 건조시킨 다음 실험에 사용하였다. The camellia used in this experiment was collected from the wild camellia which is native to Camellia japonica in Cheongbuksan, Jangheung - gun, Jeonnam Province, in February - March, young leaves in April - May, and young leaves in June - August Respectively. The antimicrobial activity of Gram positive bacteria was Bacillus subtillis , Streptomyces fradiae and Staphylococcus aureus were used, and Escherichia coli , Pseudomonas aeruginosa , Enterobacter spp. C1036 and Salmonella typhimurium , respectively. The green leaf samples of camellia were powdered to be suitable for extraction, methanol of 10 times the weight of the sample was added, extracted at 40 ° C for 5 to 6 hours, filtered, and the extract solvent was removed using a vacuum concentrator and dried using a freeze dryer And then used in the experiment.

순수 분리된 각 균주의 단일집락을 취해 1 백금이 취해 10㎖의 균 생육 액체배지에 접종하여 각각 균주의 생육적온에서 18~24시간씩 3회 배양한 후 항균활성 시험균주로 사용하였다. 항균성 시험용 평판배지의 조제는 각각의 15%의 한천이 첨가된 생육배지를 멸균하여 petridish에 15㎖씩 분주하여 기층용 배지를 응고시키고, 0.7% 한천이 첨가된 중층용 배지를 각각 5㎖씩 시험관에 분주하여 멸균한 후, 각종 시험균액(멸균식염수로 균현탁액을 만들어 균 농도를 660㎚에서 흡광도 0.3이 되게 한 균현탁액) 0.1㎖를 무균적으로 가하여 잘 혼합한 다음 기층용 배지 위에 분주한 다음 고르게 응고시켜 2중의 균접종 중층배지를 만들어 사용하였다. 동백나무 부위별 추출물의 항균활성 검색은 한천배지 확산법(disc plate method)으로 측정하였다(Piddocket, 1990; Bauer et al., 1996). 즉, 1, 5, 10, 15㎎/㎖ 농도의 부위별 동백나무 메탄올 추출물을 0.45㎛ membrane filter(Millipore Co., USA)로 여과하여 제균한 다음 멸균된 filter paper disc(Toyo roshi kaisha, 8mm)에 50㎕씩 흡수시킨 후, 추출용매를 무균적으로 풍건하여 완전히 날려 보내고 각각 균의 생육적온에서 24~48시간 동안 배양한 다음 paper disc 주변에 형성된 clear zone의 직경(㎜)을 측정하여 항균활성을 비교하였다. 이때 각 시료를 녹이기 위해 사용한 용매 및 계면활성제에 대한 공실험을 실시하였다.A single colony of each pure strain was taken and platelets were taken in 10 ml of microbial broth and incubated for three times at a temperature of 18-24 hours. To prepare the plate culture medium for the antimicrobial activity test, 15 ml of each agar medium was sterilized, and 15 ml of each medium was dispensed into petridish to coagulate the medium for the base layer. The medium for medium layer to which 0.7% , 0.1 ml of a test suspension (a suspension of the bacteria in which the bacterial suspension was made to have an absorbance of 0.3 at 660 nm by making sterilized saline solution) was aseptically added and mixed well, and then the mixture was dispensed on the medium for the base layer And uniformly solidified to prepare a double-medium inoculated medium. The antimicrobial activity of camellia extract was determined by disc plate method (Piddocket, 1990; Bauer et al ., 1996). The filter paper discs (Toyo roshi kaisha, 8 mm) were sterilized by filtration with 0.45 μm membrane filter (Millipore Co., USA) at 1, 5, 10 and 15 mg / , The extract solvent was aseptically air-dried and completely blown. After culturing for 24 to 48 hours at the appropriate temperature of each microorganism, the diameter (mm) of the clear zone formed around the paper disc was measured to determine the antibacterial activity Were compared. At this time, the solvent and the surfactant used to dissolve each sample were tested.

실험결과를 살펴보면, disc에 점적한 각 부위별 추출물의 농도가 증가할수록 항균활성이 크게 나타났다. 즉 농도가 증가할수록 항균 활성을 나타내는 inhibition zone의 크기가 증가하여 어린잎 추출물의 경우 B. subtilis , S. fradiae, P. aeruginosa, 및 S. typhimurium 및 에 대해 15㎎/㎖ 농도에서 13㎜의 억제환으로 강력한 활성을 나타내었다. 따라서 동백나무에서도 어린잎 부위의 추출물은 그람양성균과 그람음성균에 대해 넓은 항균력을 지니고 있음을 확인할 수 있었다. 이 중에서 S. aureus E. coli에서 가장 민감하게 반응하여 어린잎 추출물 5㎎/㎖ 농도를 투여하였을 때 10㎜의 억제효과을 나타내었다. 이에 반해 성숙한 잎 추출물은 P. aeruginosa에 대해서만 15㎎/㎖ 농도에서 6~10㎜의 항균활성을 보였고, 꽃봉오리 추출물은 P. aeruginosaEnterobacter spp. C1036균주에 15㎎/㎖ 농도로 첨가하였을 때 각각 8㎜, 9㎜의 억제효과를 나타내었다. 표 1은 동백나무(Camellia japonica)의 다른 부위에서 추출물에서 항균 활성( Antibacterial activities of methanol extracts in different sections of Camellia japonica)을 나타낸다. The results of the experiment showed that the antimicrobial activity was increased as the concentration of the extracts of each part dropped on the disc. As the concentration increased, the size of the inhibition zone showing the antimicrobial activity was increased. For the B. subtilis , S. fradiae , P. aeruginosa , and S. typhimurium in the young leaf extract, inhibition at 13 mg / Ring. Therefore, it was confirmed that the extracts of young leaves in Camellia have wide antibacterial activity against Gram - positive bacteria and Gram - negative bacteria. Among them, S. aureus and E. coli reacted most sensitively and showed inhibitory effect of 10 ㎜ when 5 mg / ㎖ of young leaf extract was administered. In contrast, mature leaf extract showed a 15㎎ / ㎖ antimicrobial activity of the 6 ~ 10㎜ at concentrations only for P. aeruginosa, bud extract of P. aeruginosa and Enterobacter spp . C1036 strain at a concentration of 15 mg / ml, the inhibitory effect was 8 mm and 9 mm, respectively. Table 1 shows the antibacterial activity (Antibacterial activities of methanol extracts in different sections of Camellia japonica) in the extract from other parts of the Camellia (Camellia japonica).

Microorganisms       Microorganisms Conc.
(mg/ml)
Conc.
(mg / ml)
Size of inhibition zone(mm)Size of inhibition zone (mm)
YL YL MLML FWB FWB FWFW BKBK BHBH SDSD G(+)G (+) Bacillus Bacillus subtilissubtilis 1  One -- -- -- -- -- -- -- 5 5 99 -- -- -- -- -- -- 10 10 1111 -- -- -- -- -- -- 15 15 1313 -- -- -- -- -- -- StreptomycesStreptomyces fradiae fradiae 1 One -- -- -- -- -- -- -- 5 5 77 66 55 -- -- -- -- 10 10 1212 88 77 -- -- -- -- 15 15 1313 1010 88 -- -- -- -- Staphylococcus aureusStaphylococcus aureus 1 One -- -- -- -- -- -- -- 5 5 1010 -- 66 -- -- -- -- 10 10 1111 -- 88 -- -- -- -- 15 15 1212 -- 99 -- -- -- -- G(-)G (-) EscherichiaEscherichia colicoli 1 One -- -- -- -- -- -- -- 5 5 1010 -- -- -- -- -- -- 10 10 1111 -- -- -- -- -- -- 15 15 1212 -- -- -- -- -- -- PseudomonasPseudomonas aeroginosa aeroginosa 1 One -- -- -- -- -- -- -- 5 5 99 -- -- -- -- -- -- 10 10 1111 -- -- -- -- -- -- 15 15 1313 -- -- -- -- -- -- Enterobacter spp. C1036 Enterobacter spp. C1036 1 One -- -- -- -- -- -- -- 5 5 88 -- -- -- -- -- -- 10 10 1010 -- -- -- -- -- -- 15 15 1212 -- -- -- -- -- -- Salmonella typhimuriumSalmonella typhimurium 1  One -- -- -- -- -- -- -- 5  5 -- -- -- -- -- -- -- 10  10 88 -- -- -- -- -- -- 15  15 99 -- -- -- -- -- --

본 명세서에서 동백나무의 부위별 메탄올 추출물에 함유된 페놀성 물질의 함량에 따라서 항균활성의 차이가 나타남을 알 수 있었다. 이상과 같은 결과로 보아 동백나무의 어린잎 추출물의 항균활성은 페놀성 물질의 함량에 따라서 차이가 나타났으며, 페놀성 물질의 함량이 높을수록 항균활성이 높아 구강조성물 제조시 천연항균제로서의 사용 가능성이 높은 것으로 판단된다.In the present specification, it was found that the antimicrobial activity varies according to the content of the phenolic substance contained in the methanol extract of the camellia. As a result, the antimicrobial activity of young leaves extract of Camellia japonica differed according to the content of phenolic substances, and the higher the content of phenolic substances, the higher the antimicrobial activity. Thus, the use of natural antibacterial agent .

2. 잇몸조직의 조기노화를 예방하는 항산화활성 분석2. Antioxidant activity analysis to prevent premature aging of gum tissue

본 명세서에서는 세포의 대사과정 중 생성되는 활성산소종에 의한 잇몸의 산화적 스트레스(oxidative stress)는 잇몸의 조기노화를 유발하는 원인으로 작용하므로 이를 개선 또는 예방할 수 있는 항산화 효과를 평가하는 하나의 지표로 DPPH 소거능, 항산화물질, 항산화효소 활성 분석을 이용하였다. In this specification, the oxidative stress of the gum due to active oxygen species generated during the metabolism of cells serves as a cause of premature aging of the gum, and thus, one index for evaluating the antioxidative effect capable of improving or preventing the gum DPPH scavenging activity, antioxidant activity, and antioxidant enzyme activities were used.

1) 폴리페놀 함량 분석1) Analysis of polyphenol contents

페놀성 화합물은 식물계에 널리 분포되어 있는 2차 대사산물의 하나로서 다양한 구조와 분자량을 가진다. 이들은 phenolic hydrowyl(OH)기를 가지기 때문에 단백질 및 기타 거대 분자들과 쉽게 결합하며, 항산화, 항암 등의 다양한 생리활성을 가진다. 본 실험에서는 동백잎의 성숙단계별로 추출물에 존재하는 총 페놀함량을 tannic acid를 기준물질로 하여 측정하였다.Phenolic compounds are one of the secondary metabolites widely distributed in plants and have various structures and molecular weights. Because they have a phenolic hydrowyl (OH) group, they bind easily with proteins and other macromolecules, and have various physiological activities such as antioxidant and anti-cancer. In this experiment, total phenol contents of extracts were measured with tannic acid as a reference material for each stage of maturity of camellia leaves.

분석결과, 7월에 채취한 동백잎에서 740.6 ㎍/㎎으로 가장 높은 페놀함량을 보였고, 그 다음으로는 6월에 채취한 6월에 채취한 잎에서 737.9 ㎍/㎎, 8월에 채취한 잎에서 734.6 ㎍/㎎, 5월에 채취한 잎에서 721.6 ㎍/㎎ 페놀함량을 보였으며, 3월에 채취한 잎에서 368.2 ㎍/㎎, 4월에 채취한 잎에서 333.6 ㎍/㎎, 1월에 채취한 잎에서 329.8 ㎍/㎎, 2월에 채취한 잎에서 327.4 ㎍/㎎, 전년12월에 채취한 잎에서 291.5 ㎍/㎎을 보였다. 5월부터 8월까지는 721.6 ~ 740.6 ㎍/㎎로 비교적 높은 페놀함량을 보였으며, 전년 12월부터 4월까지는 291.5 ~ 368.2 ㎍/㎎로 낮은 함량을 보였다. The results showed that the highest phenolic content was found in camellia leaves collected in July, 740.6 ㎍ / ㎎, followed by 737.9 ㎍ / ㎎ in leaves collected in June, and leaves collected in August In leaves collected in May, and 733.6 ㎍ / ㎎ in leaves collected in May, and 368.2 ㎍ / ㎎ in leaves collected in March, and 333.6 ㎍ / 329.8 ㎍ / ㎎ in leaves collected, 327.4 ㎍ / ㎎ in leaves collected in February, and 291.5 ㎍ / ㎎ in leaves collected in December last year. From May to August, the content of phenol was relatively high, ranging from 721.6 to 740.6 ㎍ / ㎎, and the content of phenol was 291.5 ~ 368.2 ㎍ / ㎎ during December to April of last year.

도 1 및 표 2는 각 월에 따른 동백잎의 메탄올 추출물의 페놀 함량(Total phenolic contents of methanol extracts from each month of Camellia japonica L. leaves)을 나타내고 있다.1 and Table 2 show the phenolic contents of methanol extracts of camellia leaves (total phenolic contents of methanol extracts from each month of Camellia japonica L. leaves).

SampleSample Collection timeCollection time Total phenolics(㎍/㎎)1 ) Total phenolics (㎍ / mg) 1 ) Leaves
Leaves
Dec. 2005Dec. 2005 291.5 ± 8.212) 291.5 ± 8.21 2)
Jan. 2006Jan. 2006 329.8 ± 10.22329.8 ± 10.22 Feb. 2006Feb. 2006 327.4 ± 8.45327.4 ± 8.45 Mar. 2006Mar. 2006 368.2 ± 10.55368.2 ± 10.55 Apr. 2005Apr. 2005 333.6 ± 18.35333.6 ± 18.35 May 2005May 2005 721.6 ± 1.13721.6 + 1.13 Jun. 2005Jun. 2005 737.9 ± 11.03737.9 ± 11.03 Jul. 2005Jul. 2005 740.6 ± 9.80740.6 + - 9.80 Aug. 2005Aug. 2005 734.6 ± 10.45734.6 ± 10.45 Flower
Flower
Apr. 2005Apr. 2005 635.5 ± 9.89635.5 ± 9.89
May 2005May 2005 649.7 ± 6.22649.7 ± 6.22

①Sample was analyzed using tannic acid as a standard.① Sample was analyzed using tannic acid as a standard.

②Each value is means±S.D (n=3)②Each value is means ± SD (n = 3)

2) DPPH radical 소거능 분석2) Analysis of DPPH radical scavenging ability

각 농도별로 시료를 메탄올에 녹인 뒤 160μL씩 취하여 1.5×104M 농도로 메탄올에 용해시킨 DPPH 용액 40μL와 잘 혼합하였다. 이 반응 혼합액을 실온에서 30분간 방치한 후, microplate reader spectrophotometer VERSAmax로 520nm에서 흡광도를 측정하였다. 시료를 첨가하지 않은 대조군과 비교하여 free radical 소거활성을 백분율로 나타내고 50% 소거농도(IC50는 μg/mL 혹은 μM로 표현)을 계산하였다. 측정치는 3회 반복 실험하여 얻은 결과를 평균한 값으로 나타내었으며 기존의 항산화제인 Vit C, Vit E 및 BHT와 비교하였다.For each concentration, 160 μL of the sample was dissolved in methanol and mixed well with 40 μL of a DPPH solution dissolved in methanol at a concentration of 1.5 × 10 4 M. The reaction mixture was allowed to stand at room temperature for 30 minutes, and the absorbance was measured at 520 nm with a microplate reader spectrophotometer VERSAmax. The free radical scavenging activity was expressed as a percentage and the 50% scavenging concentration (IC50 expressed in μg / mL or μM) was calculated as compared to the control without the sample. The measured values were expressed as the average value obtained by three repeated experiments and compared with the conventional antioxidants Vit C, Vit E and BHT.

분석결과를 살펴보면, 각 시기별(05. 12 ~ 06. 8) 동백 잎 추출물을 100 ㎍/㎖ 농도에서 DPPH법에 의해 항산화 활성을 측정한 결과, 12월~2월 동백 잎 추출물에서는 30% 미만의 낮은 활성을 보였으나 3월 동백 잎 추출물은 DPPH radical 소거율이 70.89%로 급격히 증가하였고 5~6월에 채취한 동백 잎 추출물에서 90% 이상의 소거율을 보여 항산화 활성이 가장 높은 시기로 확인되었다. 이는 천연항산화제인 ascorbic acid(Vit C)와 견주어 유사한 항산화 효과를 보였고 합성항산화제인 BHT보다 월등히 높은 항산화 활성을 나타내었다.   The antioxidant activity of camellia leaf extracts was measured by DPPH method at 100 ㎍ / ㎖ concentration for each period (05.12 ~ 06.8). From December to February, it was less than 30% . However, the DPPH radical scavenging rate increased rapidly to 70.89% in March, and the scavenging rate was more than 90% in the camphor leaf extract collected from May to June, indicating the highest antioxidant activity . The antioxidant activity was similar to that of ascorbic acid (Vit C), which is a natural antioxidant, and showed much higher antioxidative activity than BHT which is a synthetic antioxidant.

도 2 및 표 3은 각 월에 따른 동백잎의 메탄올 추출물의 DPPH radical 소거능(DPPH radical scavenging activity of methanol extracts from each month of Camellia japonica leaves)을 나타내고 있다. 2 and 3 show DPPH radical scavenging activity of methanol extracts from Camellia japonica leaves of methanol extract of camellia leaves according to each month.

SampleSample Collection timeCollection time Scavenging activity (100 ㎍/㎖)Scavenging activity (100 [mu] g / ml) IC50 (㎍/ml)* IC 50 (/ / ml) * Leaves Leaves Dec. 2005Dec. 2005 28.79 ± 1.2328.79 ± 1.23 179.88179.88 Jan. 2006Jan. 2006 26.75 ± 0.8326.75 + - 0.83 184.32184.32 Feb. 2006Feb. 2006 24.97 ± 0.7824.97 ± 0.78 190.48190.48 Mar. 2006Mar. 2006 70.89 ± 1.0270.89 ± 1.02 57.8557.85 Apr. 2006Apr. 2006 84.49 ± 2.1884.49 + - 2.18 39.7839.78 May 2006May 2006 92.54 ± 0.1692.54 + 0.16 ≤ 12.5≤ 12.5 Jun. 2006Jun. 2006 93.30 ± 0.0493.30 ± 0.04 ≤ 12.5≤ 12.5 Jul. 2006Jul. 2006 76.98 ± 1.5076.98 1.50 48.7748.77 Aug. 2006Aug. 2006 74.64 ± 1.1274.64 ± 1.12 46.7346.73 ascorbic acidascorbic acid 96.19 ± 0.0496.19 + 0.04 ≤ 12.5≤ 12.5 BHTBHT 31.43 ± 1.2931.43 + - 1.29 198.93198.93

3) 동백잎 효소추출물의 catalase 활성 분석3) Analysis of catalase activity of Camellia sinensis leaf extract

catalase는 생체내의 유해한 산소들을 신속히 처리하여 세포를 보호하는 항산화계 효소로 항산화효소 H2O2를 분해 소거하는 대표적인 효소이다. 항산화효소(antioxidative enzyme)가 풍부한 음식을 섭취하는 것은 암이나 심장병 등의 발병가능성을 줄여준다고 생각되어왔으며 항산화효소가 신체의 노화현상을 지연시킨다는 연구보고도 있다. 이러한 항산화효소가 풍부한 보충제로는 알파 토코페롤(α-tocopherol)과 같은 지용성 비타민 E, 베타 카로틴(β-carotene), 수용성 비타민 C, 셀레늄(Se), 녹차, 클로렐라, 녹황색 야채 등이 있다. 그 중에서도 비타민 E는 세포막과 관련이 많기 때문에 인간에게 있어서 가장 중요한 지용성 항산화제(antioxidant)로 알려져 있으며 비타민 C는 수용성 과산화 radical을 제거하고 또 환원된 비타민 E를 재생시키는 역할도 한다. catalase is an antioxidant enzyme that rapidly treats harmful oxygen in vivo and protects cells. It is a typical enzyme that decomposes and eliminates antioxidant enzyme H 2 O 2 . Antioxidant enzyme-rich foods have been thought to reduce the likelihood of developing cancer or heart disease, and antioxidant enzymes have been reported to delay the aging of the body. These antioxidant enzyme-rich supplements include fat-soluble vitamin E such as alpha-tocopherol, beta-carotene, water-soluble vitamin C, selenium (Se), green tea, chlorella and greenish-yellow vegetables. Vitamin E is known to be the most important lipid-soluble antioxidant in humans because it is related to cell membranes. Vitamin C also plays a role in removing water-soluble peroxide radicals and regenerating reduced vitamin E.

본 실험에서 catalase활성은 Aebi (1984) 방법에 의하여 측정하였다. 50 mM potassium phosphate (pH 7.0)에 10 mM H2O2 와 반응 효소액을 가하였다. 240nm에서 2분간의 흡광도 변화를 관찰하고 1분동안에 1uM의 H2O2를 분해하는 효소의 양을 1 unit으로 하였다. In this experiment, catalase activity was measured by Aebi (1984) method. To 50 mM potassium phosphate (pH 7.0) was added 10 mM H 2 O 2 And a reaction enzyme solution were added thereto. The change in absorbance at 240 nm for 2 minutes was observed, and the amount of enzyme degrading 1 uM H 2 O 2 was set to 1 unit over 1 minute.

동백의 신엽(어린 잎)과 성엽(성숙 잎) 그리고 화기(꽃)를 채취하여 catalase 활성을 측정한 결과, 녹차와 동백의 부위별 활성도를 비교시 성엽 추출물의 활성이 가장 높았으며, 신엽과 화기의 경우 거의 비슷한 활성을 나타내었다. 신엽의 경우 녹차 잎과 비교시 가장 낮은 활성도를 나타내었다. 이 결과에서 동백의 성엽은 지금까지의 보고된 녹차의 활성도보다 높은 활성을 보이고 있어 H2O2 제거능이 높은 물질을 함유하고 있다고 관찰되어진다. The catalase activities of the cambial larvae, young leaves, and mature leaves were investigated. The activities of green tea and camellia were the highest in leaf extracts, Showed almost similar activity. In the case of fresh leaves, the lowest activity was observed compared with green tea leaves. From these results, it is observed that camellia seedlings have higher activity than the green tea activity reported so far and contain substances with high H 2 O 2 removal ability.

도 3은 동백잎 효소추출물의 catalase 활성(Catalase activities of extracts from each part of camellia)을 나타내고 있다.FIG. 3 shows the catalase activities of extracts of Camellia sinensis from various parts of camellia.

3. 성분 분석3. Component analysis

1) 동백 어린 잎(신엽)의 엽위별 성분 함량 분석1) Content analysis of camellia sinensis leaf

총질소는 제1엽이 4.21%로 가장 많았고, 제3엽, 제4엽 등 전개 후 성숙됨에 따라 감소되는 경향이었다. 총 유리아미노산은 지엽과 줄기에 각각 2.12%, 2.27%로 가장 많았다. 카테킨은 제1엽에서 17.8%였고 잎이 아주 미숙한 상태 일때와 성숙이 진행됨에 따라 그 함량이 감소하였으며 카페인 역시 엽위가 진전 할수록 약간 감소하는 경향이었다. 비타민C는 엽위가 전개 될수록 약간 증가하다가 다시 감소하는 경향이었다. 표 4는 동백 어린 잎(신엽)의 엽위별 성분 함량을 나타내고 있다.Total nitrogen was the highest in the first leaf (4.21%) and decreased in the third leaf and the fourth leaf after ripening. Total free amino acids were 2.12% and 2.27% in leaf and stem, respectively. The content of catechin was 17.8% in the first leaf and decreased as the leaf became very immature and maturation progressed. Vitamin C tended to increase slightly as the leaf width developed, then decreased again. Table 4 shows the content of leaf components in camellia sinensis (new leaf).

구분division 총질소Total nitrogen 총유리아미노산Total free amino acids 카테킨Catechin 카페인Caffeine 비타민CVitamin C 제1엽1st leaf 4.214.21 0.520.52 17.8017.80 2.612.61 33.2733.27 제2엽Second leaf 4.134.13 0.590.59 17.6317.63 2.522.52 58.9158.91 제3엽Third leaf 4.104.10 0.690.69 17.2817.28 2.442.44 69.6369.63 제4엽Fourth leaf 4.114.11 0.730.73 16.4816.48 2.432.43 51.9751.97 제5엽Fifth leaf 4.094.09 0.820.82 16.2616.26 2.352.35 64.9864.98 제6엽6th leaf 4.064.06 0.860.86 14.9614.96 2.292.29 43.3143.31

2) 동백잎의 유리당의 함량 분석2) Analysis of free sugar content of camellia leaves

동백잎에 함유된 4가지 종류의 유리당 함량을 분석한 결과, sucrose 함량이 12.8nmol/0.1mg 로 가장 높았으며, fructose, glucose, maltos 순으로 함유되어 있었다. 표 5는 동백나무 잎으로부터 추출된 추출물의 유리당의 함량(Free sugar contents of camellia leaf extracts (unit, nmol/0.1mg))을 나타내고 있다. The content of free sugar in Camellia japonica leaf was highest in sucrose content of 12.8 nmol / 0.1 mg, followed by fructose, glucose and maltos. Table 5 shows the content of free sugars of camellia leaf extracts (unit, nmol / 0.1 mg) of the extracts extracted from camellia leaves.

GlucoseGlucose FructoseFructose SucroseSucrose MaltoseMaltose TotalTotal 3.33.3 6.76.7 12.812.8 2.12.1 24.924.9

4. 동백나무 잎으로부터 추출된 추출물의 구강유해균에 대한 항균 활성 4. Antimicrobial activity of extracts extracted from Camellia sinensis on oral harmful bacteria

고령자 구강에서 많이 발생하는 S. mutans는 치아우식증(Dental caries; 충치질환)을 유발하는 초기 원인균으로, S. mutans에 의해 설탕, 전분 등이 분해되면서 생성되는 산(acid)에 의해 치아의 법랑질이 손상되어 충치가 발생한다. 구강 캔디다증 (Candidiasis, Thrush, 아구창, 구내염): Candida albicans 감염에 의해 구강점막의 표면에 회백색 또는 유백색 반점이 발생. 특히 고령자들 중 의치 사용자나 소모성 질환 또는 면역질 환자에게 많이 발생한다.S. mutans, which occurs frequently in the oral cavity of elderly people, is an early causative agent causing dental caries (dental caries). It is caused by the acid generated by the decomposition of sugar and starch by S. mutans, Damaged and cavities occur. Candidiasis, Thrush: Candida albicans infection causes grayish or milky spots on the surface of the oral mucosa. Especially in elderly denture users, consuming diseases or immunity patients.

paper disc method을 사용하여 분리된 동백나무 잎으로부터 추출된 추출물 및 동백나무 잎으로부터 추출된 추출물이 함유된 치약의 항균력을 분석하였다. 순수 분리된 각 균주의 단일집락을 취해 10㎖의 균 생육 액체배지에 접종하여 각각 균주의 생육적온에서 18~24시간씩 3회 배양한 후 항균활성 시험균주로 사용하였다. 항균성 시험용 평판배지의 조제는 각각 균주의 15%의 한천이 첨가된 생육배지를 멸균하여 petri dish에 15㎖씩 분주하여 기층용 배지를 응고시키고, 각각의 시험균 농도를 650㎚에서 optical density(O,D)값이 0.4(106 CFU/mL)가 되게 한 후 0.7% 한천이 첨가된 중층용 배지에 무균적으로 가하여 잘 혼합한 다음 기층용 배지 위에 분주한 다음 고르게 응고 시켜 2중의 균 접종 중층배지를 제조하였다. 충분히 굳은 고체배지 위에 멸균된 8㎜ paper disc를 올려놓은 후, 시료 농도별로 30㎕씩 disc에 흡수시킨 다음 37℃에서 24시간동안 배양한 후 disc 주변의 clear zone을 관찰하므로서 구강유해균에 대한 살균력을 분석하였다.The paper disc method was used to analyze the antimicrobial activity of the extracts from the camellia leaves and the toothpastes containing the extracts from the camellia leaves. A single colony of each isolate was isolated and inoculated into 10 ml of the broth culture medium. The broth was cultured for three times at a temperature of 18-24 hours at the appropriate temperature of the strain, and then used as an antimicrobial activity test strain. For the preparation of the plate culture medium for the antimicrobial activity test, 15 ml of agar was added to 15 ml of each agar medium, and 15 ml of the agar medium was added to the petri dish to coagulate the culture medium. , D) was 0.4 (10 6 CFU / mL), and the mixture was aseptically added to a medium containing 0.7% agar. The mixture was then mixed on a medium for the bed, and then solidified uniformly. Medium was prepared. The sterilized 8 mm paper disc was placed on a solid medium which was sufficiently hard, and then 30 μl of each sample was absorbed into the disc. After incubation at 37 ° C for 24 hours, the clear zone around the disc was observed, Respectively.

도 4는 충치 유발균 S. mutans에 대한 동백나무 잎으로부터 추출된 추출물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL, ④ 100mg/mL)을 나타낸다. Fig. 4 shows the antimicrobial activity (① 20 mg / mL, ② 40 mg / mL, ③ 80 mg / mL, and ④ 100 mg / mL) of the extract extracted from camellia leaves against the carotid bacterium S. mutans.

도 5는 치아우식 유발균 S. sobrinus에 대한 동백나무 잎으로부터 추출된 추출물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL, ④ 100mg/mL)을 나타낸다.Fig. 5 shows the antimicrobial activity (① 20 mg / mL, ② 40 mg / mL, ③ 80 mg / mL, and ④ 100 mg / mL) of the extract extracted from camellia leaves against dental caries-inducing S. sobrinus.

도 6은 구내염의 원인균 C. albicans에 대한 동백나무 잎으로부터 추출된 추출물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL, ④ 100mg/mL)을 나타낸다.Figure 6 shows the antimicrobial activity of extracts from camellia leaves against the causative organism C. albicans (20 mg / mL, 40 mg / mL, 80 mg / mL, and 100 mg / mL).

표 6은 충치 유발균 S. mutans 및 치아우식 유발균 S. sobrinus, 구내염의 원인균 C. albicans에 대한 동백나무 잎으로부터 추출된 추출물의 항균활성을 정리한 것이다.Table 6 summarizes the antimicrobial activities of Camellia sinensis extracts from Camellia sinensis on C. suicide, S. sobrinus, C. albicans, and C. cannabis.

동백나무 잎으로부터 추출된 추출물의 clear zone (단위:mm)Clear zone of extract from camellia leaves (Unit: mm) Concentration Concentration Microbial strainsMicrobial strains S. mutansS. mutans S. sobrinusS. sobrinus C. albicansC. albicans controlcontrol -- -- -- ① 20mg/ml① 20mg / ml 22 22 33 ② 40mg/ml② 40mg / ml 33 33 44 ③ 80mg/ml③ 80mg / ml 44 44 55 ④ 100mg/ml    ④ 100mg / ml 55 55 66

2.세치제 조성물의 구강유해균에 대한 항균 활성2. Antimicrobial activity of erectile composition against oral harmful bacteria

도 7은 충치 유발균 S. mutans에 대한 세치제 조성물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL(1mm), ④ 100mg/mL(3mm))을 나타낸다.Fig. 7 shows the antimicrobial activity (① 20 mg / mL, ② 40 mg / mL, ③ 80 mg / mL (1 mm), and 100 mg / mL (3 mm)) of the anticancer composition against the cavity-inducing S. mutans.

도 8은 치아우식 유발균 S. sobrinus에 대한 세치제 조성물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL, ④ 100mg/mL)을 나타낸다.Fig. 8 shows the antimicrobial activity (① 20 mg / mL, ② 40 mg / mL, ③ 80 mg / mL, and ④ 100 mg / mL) of a cicatricial composition against dental caries-inducing S. sobrinus.

도 9은 구내염의 원인균 C. albicans에 대한 세치제 조성물의 항균활성(① 20mg/mL, ② 40mg/mL, ③ 80mg/mL, ④ 100mg/mL)을 나타낸다.Fig. 9 shows the antimicrobial activity (① 20 mg / mL, ② 40 mg / mL, ③ 80 mg / mL, and ④ 100 mg / mL) of the anticancer composition against C. albicans causing the stomatitis.

표 7은 충치 유발균 S. mutans 및 치아우식 유발균 S. sobrinus, 구내염의 원인균 C. albicans에 대한 세치제 조성물의 항균활성을 정리한 것이다.Table 7 summarizes the antimicrobial activity of the antiseptic composition against the carotid-inducing bacteria S. mutans, the dental caries-inducing bacteria S. sobrinus, and the causative organism of stomatitis C. albicans.


세치제 조성물의 clear zone (단위:mm)Clear zone of the sheath composition (unit: mm) Concentration Concentration Microbial strainsMicrobial strains S. mutansS. mutans S. sobrinusS. sobrinus C. albicansC. albicans controlcontrol -- -- -- ① 20mg/ml① 20mg / ml -- 33 33 ② 40mg/ml② 40mg / ml -- 44 55 ③ 80mg/ml③ 80mg / ml 1One 55 55 ④ 100mg/ml    ④ 100mg / ml 33 66 66

산수유Corn oil

산수유는 층층나무과(Cornaceae)에 속하는 낙엽활엽 소교목, 산지나 인가부근에 서식하는 식물로 일반적으로 열매의 육질을 약용으로 사용한다. 주요 효능은 요실금, 당뇨병, 혈압강하, 항암작용, 수렴작용, 피부진균(황색포도상구균, 황색 백선균)에 대한 항균작용, 청각세포 보호, 정력보강, 항산화, 소염 기능이 있는 것으로 보고 되었으며, 주요 성분으로는 모로니사이드(Morroniside), 로가닌(Loganin), 코르닌(Cornin(Verbenalin)), 사포닌(Saponin), 탄닌(Tanin), 우르솔닉산(Ursolic acid), 갈릭산(Gallic acid), 마릭산(Malic acid), 타타릭산(Tartaric acid), 비타민A 등이 함유되어 있다.Cornus officinalis is a deciduous broad-leaved arboreous tree belonging to the genus Cornaceae. It is a plant that lives in the vicinity of the mountainous region, and generally uses the flesh quality of the fruit as medicinal. Major efficacy has been reported to have antimicrobial action against skin incontinence, diabetes, hypotension, anticancer action, convergence, skin fungi (Staphylococcus aureus, yellow pseudomonas), auditory cell protection, tugging, antioxidant, Such as Morroniside, Loganin, Cornin (Verbenalin), Saponin, Tannin, Ursolic acid, Gallic acid, Malic acid, Tartaric acid, Vitamin A and others.

1. 잇몸조직의 조기노화를 예방하는 항산화효능 분석1. Antioxidant efficacy analysis to prevent premature aging of gum tissue

본 명세서에서는 세포의 대사과정 중 생성되는 활성산소종에 의한 잇몸의 산화적 스트레스(oxidative stress)는 잇몸의 조기노화를 유발하는 원인으로 작용하므로 이를 개선 또는 예방할 수 있는 항산화 효과를 평가하는 하나의 지표로 DPPH 소거능, 항산화물질, 항산화효소 활성 분석을 이용하였다.In this specification, the oxidative stress of the gum due to active oxygen species generated during the metabolism of cells serves as a cause of premature aging of the gum, and thus, one index for evaluating the antioxidative effect capable of improving or preventing the gum DPPH scavenging activity, antioxidant activity, and antioxidant enzyme activities were used.

1) 추출물의 Polyphenol 함량 1) Polyphenol content of extract

총 폴리페놀함량은 Folin-Denis법에 따라 약간 변형하여 측정하였다. 산수유로부터 분리된 추출물 0.1 g에 methanol 10ml을 가하여 70℃에서 30분 동안 추출한 후 1mg/ml로 만들어서 사용하였다. 검액 50 ㎕에 증류수 650 ㎕를 넣은 후 Folin-Denis reagent를 50 ㎕ 가하여 3분동안 실온에서 반응시켰다. 반응시킨 후 10% Na2CO3 포화용액을 100 ㎕을 첨가하고, 최종 볼륨을 1mL로 맞추기 위해 증류수 150 ㎕을 넣어 잘 혼합시켰다. 37℃ water bath에서 1시간 반응시킨 후 UV-Vis spectrophotometer를 사용하여 725 nm에서 흡광도를 측정하였다. 공시험은 시료 용액 대신 methanol 용액을 동일하게 처리하며, 표준곡선은 tannic acid (Sigma Co., USA)의 농도를 0~500 ㎍/mL 이 되도록 하고 이로부터 총 페놀함량을 구하였다.Total polyphenol content was measured by Folin-Denis method. To 0.1 g of the extract isolated from corn oil, 10 ml of methanol was added, and the mixture was extracted at 70 ° C for 30 minutes and made into 1 mg / ml. 650 μl of distilled water was added to 50 μl of the sample solution, 50 μl of Folin-Denis reagent was added, and the mixture was reacted at room temperature for 3 minutes. After the reaction, 100 μl of a saturated solution of 10% Na 2 CO 3 was added, and 150 μl of distilled water was added to adjust the final volume to 1 ml. After reacting in a water bath at 37 ° C for 1 hour, the absorbance was measured at 725 nm using a UV-Vis spectrophotometer. In the blank test, the methanol solution was treated in place of the sample solution, and the standard curve was such that the concentration of tannic acid (Sigma Co., USA) was 0 to 500 μg / mL, and the total phenol content was determined therefrom.

폴리페놀 함량을 분석한 결과, 표 8(추출물의 총 폴리페놀 함량)에서와 같이 27.17㎍/㎖ 함유되어 있었다.  Analysis of polyphenol contents showed that 27.17 / / ml was contained as in Table 8 (total polyphenol content of the extract).

Plant name(Parts used)Plant name (Parts used) Total Polyphenolics(㎍/㎖)Total Polyphenolics (占 퐂 / ml) 산수유 (열매)Corn oil (fruit) 27.1727.17

2) 추출물의 DPPH radical 소거능 분석2) Analysis of DPPH radical scavenging ability of extract

항산화활성 검색은 DPPH법을 이용하여 시료의 radical 소거효과를 측정하는 Blois의 방법을 약간 변형하여 측정하였다. 1×10-4M DPPH와 농도별 추출물을 각각 100 ㎕씩 취하여 혼합한 30분간 암 상태에서 방치한 후 잔존 radical 농도를 ELISA Reader(Bio-RAD, USA)를 이용하여 517nm에서 측정하였다. 시료의 환원력의 크기는 라디칼 소거활성(Scavenging activity)으로 표시하며, RC50은 DPPH 농도가 1/2로 감소하는데 필요한 시료의 양(㎍)으로 나타내며 항산화 물질로 잘 알려진 BHT(butylated hydroxytoluene)와 Vit C(ascorbic acid)를 비교하였다. The antioxidant activity was measured by slightly modifying the Blois method for measuring the radical scavenging effect of the sample using the DPPH method. 100 μl of 1 × 10 -4 M DPPH and concentration-specific extracts were taken and incubated for 30 min in the dark, and the residual radical concentration was measured at 517 nm using an ELISA reader (Bio-RAD, USA). The amount of reducing power of the sample is expressed as a scavenging activity. RC 50 is expressed as the amount (㎍) of the sample required to reduce the concentration of DPPH to 1/2. BHT (butylated hydroxytoluene) and Vit C (ascorbic acid) were compared.

DPPH radical scavenging activity(%) = (Ac-As)/Ac × 100DPPH radical scavenging activity (%) = (Ac-As) / Ac x 100

위 식에서 Ac는 시료를 첨가하지 않은 대조구의 흡광도, As는 시료를 첨가한 반응구의 흡광도를 나타낸다.Where Ac is the absorbance of the control without addition of the sample and As is the absorbance of the reaction solution containing the sample.

추출물에 대하여 DPPH radical 소거능을 분석한 결과, 산수유 열매과육 추출물의 RC50 값은 234.51 ug/ml로 우수한 활성을 보였다. As a result of DPPH radical scavenging activity of the extract, the RC 50 value of the extract from corn syrup was 234.51 ug / ml.

도 10 및 표 9는 동백잎의 에탄올 추출물의 DPPH radical 소거능(DPPH radical scavenging activity of ethanol extracts from Cornus officinalis)을 나타내고 있다.10 and 9 show the DPPH radical scavenging activity of ethanol extracts from Cornus officinalis of the ethanol extract of camellia leaves.

name(Scientific name)name (Scientific name) Part usedPart used RC50 (ug/ml)RC 50 (ug / ml) 산수유(Hosta lancifolia) Hosta lancifolia ) FleshFlesh 234.51234.51 BHTBHT 101101 Vit.CVit.C 6.86.8

2) SOD 유사활성 및 CAT 활성2) SOD-like activity and CAT activity

SOD 활성은 Beauchamp and Fridovich(1971)의 방법을 응용하여 측정하였다. 50 mM carbonic buffer (pH 10.2), 0.1 mM EDTA,, 0.1mM Xanthine, 0.025 mM nitroblue tetrazolium(NBT), 효소액이 포함된 용액을 25°C에서 10분간 반응한 후 Xanthine oxidase(3.3

Figure 112015007063039-pat00001
10-6mM)를 참가하여 반응을 측정하였다. SOD 활성 측정은 550nm에 30초 단위로 5분간 흡광도를 측정하였다. SOD activity was measured by Beauchamp and Fridovich (1971). The solution containing 50 mM carbonic buffer (pH 10.2), 0.1 mM EDTA, 0.1 mM Xanthine, 0.025 mM nitroblue tetrazolium (NBT) and enzyme solution was reacted at 25 ° C for 10 minutes and then treated with Xanthine oxidase
Figure 112015007063039-pat00001
10-6mM) was added to measure the response. SOD activity was measured by absorbance at 550 nm for 5 minutes in 30 second increments.

catalase활성은 Aebi (1984) 방법에 의하여 측정하였다. 50 mM potassium phosphate (pH 7.0)에 10 mM H2O2 와 반응 효소액을 가하였다. 240nm에서 2분간의 흡광도 변화를 관찰하고 1분동안에 1uM의 H2O2를 분해하는 효소의 양을 1 unit으로 하였다. Catalase activity was measured by the Aebi (1984) method. To 50 mM potassium phosphate (pH 7.0) was added 10 mM H 2 O 2 And a reaction enzyme solution were added thereto. The change in absorbance at 240 nm for 2 minutes was observed, and the amount of enzyme degrading 1 uM H 2 O 2 was set to 1 unit over 1 minute.

표 10에 나타낸 바와 같이, SOD 활성을 측정한 결과 산수유 열매(17.8 U/mg)는 우수한 효소활성을 보였으며, CAT 활성을 분석한 결과 산수유 열매는 13.9 U/mg로서 우수한 활성을 나타내었다. As shown in Table 10, the SOD activity of the fermented soybean oil (17.8 U / mg) showed excellent enzyme activity. As a result of analysis of CAT activity, the fermented soybean oil had excellent activity as 13.9 U / mg.

도 11은 산수유 추출물의 SOD 활성(HL/F; 산수유 열매)을 나타내고 있다.Fig. 11 shows the SOD activity (HL / F) of the extract of corn oil.

SampleSample CAT activity(U/mg)CAT activity (U / mg) SOD activity(U/mg)SOD activity (U / mg) 산수유 열매Corn oil 13.913.9 17.817.8

2. 구강유해균에 대한 살균력 분석2. Analysis of sterility against oral harmful bacteria

또한 산수유 추출물의 최소살균농도 분석법(MBC: Minimum Bactericidal Concentration)을 이용한 6종의 구강질환 유발균에 대한 살균효과를 검증하였다.In addition, the bactericidal effect of six kinds of oral disease - inducing bacteria was verified by MBC (Minimum Bactericidal Concentration) method.

표 11은 산수유 추출물의 최소살균농도(Minimum bactericidal concentration of extracts from Cornus officinalis fruits)을 나타내고 있다.Table 11 shows the minimum bactericidal concentration of extracts from Cornus officinalis fruits).

MBC (mg/mL)MBC (mg / mL) AaAa 33384 33384 TfTf 43037 43037 FnFn 25586 25586 Pi 25611Pi 25611 PgPg 33277 33277 SmSm 25175 25175 >1> 1 >1> 1 0.250.25 >1> 1 1One >1> 1

* Aa 33384 : Actinobacillus actinomycetem - comitans (침습성 치주염, 잇몸질환 유발균)* Aa 33384: Actinobacillus actinomycetem - comitans (invasive periodontitis, gum disease causing bacteria)

* Tf 43037 : Tannerella forsythensis (치주염 유발균)* Tf 43037: Tannerella forsythensis

* Fn 25586 : Fusobacterium necrophorum (궤양성 구내염, 치주질환, 구취의 원인균)* Fn 25586: Fusobacterium necrophorum (ulcerative stomatitis, periodontal disease, causing bad breath)

* Pi 25611 : Prevotella intermedia (호르몬 관련 치주염 유발균)* Pi 25611: Prevotella intermedia (hormone-related periodontitis causing bacteria)

* Pg 33277 : Porphyromonas gingivalis (치주질환의 주요 원인균종)* Pg 33277: Porphyromonas gingivalis (major causative agent of periodontal disease)

* Sm 25175 : Streptococcus mutans (치아우식증의 주요 원인균종)* Sm 25175: Streptococcus mutans (a major cause of dental caries)

산수유 열매 추출물은 궤양성 구내염, 치주질환, 구취의 원인균으로 작용하는 Fusobacterium necrophorum에 대해 매우 탁월한 살균력을 나타냈으며, 치주질환의 주요 원인균인 Porphyromonas gingivalis에 대하여도 강한 살균효과를 보였다. 그 밖에도 치아우식증과 치주병의 원인균인 Actinobacillus actinomycetemcomitans와 호르몬 관련 치주염 유발균인 Prevotella intermedia, 치아우식증의 초기 원인균인 Streptococcus mutans, 호르몬 관련 치주염 유발균(Prevotella intermedia)에 대하여 저농도 수준에서 살균력을 보여 주었다.The fruit extract of Sanskrit showed excellent antimicrobial activity against Fusobacterium necrophorum, which acts as a causative organism of ulcerative stomatitis, periodontal disease and bad breath, and showed strong antiseptic effect against Porphyromonas gingivalis, a major pathogen of periodontal disease. In addition, Actinobacillus actinomycetemcomitans, a causative organism of dental caries and periodontal disease, Prevotella intermedia, a hormone-related periodontitis inducer, Streptococcus mutans, an early pathogen of dental caries, and Prevotella intermedia, were demonstrated at low levels.

배초향 Fried

한국 본초도감에서 배초향(排草香 Agastach rugosa O.Kuntze)은 일명 방아풀 ,곽향(藿香), 토곽향(土藿香)이라 불리는 꿀풀과(Labiatae)의 다년초 식물로서 지리적으로 일본, 중국, 만주, 대만 등의 동아시아 지역에 분포하며 우리 나라에서는 전국의 산야, 계곡, 약간의 습기가 있는 곳 등에 자생하고 있다. 배초향 주성분은 phenylpropanoide계 정유성분으로 주성분이 methylchavicol이고, 그밖에 anethloe, ansialdehyde 등이 그리고 terpene계 정유로 α-limonene, β-methoxycinnamaldehyde, α-pinene등이 함유 되어 있다. 약리효과는 피부진균, 황색포도상구균, 녹농균, 대장균, 이질균, 용혈성연쇄상구균, 페렴균 등의 발육을 억제하는 작용이 있다.Agastache rugosa (排草香Agastach in Korea Prime Encyclopedia rugosa O.Kuntze) is a perennial plant of Labiatae, also known as a fenugreek, hwakyeong, or tochuka, and is distributed geographically in East Asia such as Japan, China, Manchuria, and Taiwan. In our country, mountain wilderness, valleys, and some humid places in the country are alive. The main component of the syrup is phenylpropanoide essential oil component and its main component is methylchavicol. In addition, anethloe, ansialdehyde, and terpene essential oils contain α-limonene, β-methoxycinnamaldehyde and α-pinene. The pharmacological effect has an action of inhibiting the development of skin fungus, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Disease, hemolytic streptococcus, and pneumonia.

1. 배초향 정유 추출1. Refined oil extraction

깨끗하게 세척된 식물체를 일정크기로 절단하여 원형플라스크에 증류수와 함께 넣은 후, 수증기증류장치를 이용하여 5시간 동안 수증기 증류하여 투명한 정유를 획득하였다.The cleaned plant was cut into a predetermined size, put in a round flask together with distilled water, and steam distillation was performed using a steam distillation apparatus for 5 hours to obtain a transparent essential oil.

2. 항산화물질 및 항산화활성 분석2. Antioxidant and antioxidant activity analysis

본 명세서에서는 세포의 대사과정 중 생성되는 활성산소종에 의한 잇몸의 산화적 스트레스(oxidative stress)는 잇몸의 조기노화를 유발하는 원인으로 작용하므로 이를 개선 또는 예방할 수 있는 항산화 효과를 평가하는 하나의 지표로 DPPH 소거능, 항산화물질, 항산화효소 활성 분석을 이용하였다. In this specification, the oxidative stress of the gum due to active oxygen species generated during the metabolism of cells serves as a cause of premature aging of the gum, and thus, one index for evaluating the antioxidative effect capable of improving or preventing the gum DPPH scavenging activity, antioxidant activity, and antioxidant enzyme activities were used.

1) 페놀 함량 분석1) Analysis of phenol content

본 명세서에서 사용한 배초향은 시료 50g당 에탄올 500ml에 5시간 동안 heating mentle에서 열수 추출하였으며 추출액은 filter paper(No.1, Advantec)로 여과하여 50℃에서 감압농축한 후 실험에 사용하였다.The filtrate used in this specification was extracted with 500 ml of ethanol per 500 g of the sample for 5 hours under heating mentle. The extract was filtered with filter paper (No. 1, Advantec) and concentrated under reduced pressure at 50 ° C before use.

총 폴리페놀함량은 Folin-Denis법에 따라 약간 변형하여 측정하였다. 추출물 0.1 g을 methanol 10ml에 용해한 후 1mg/ml로 희석하여 사용하였다. 검액 50 ㎕에 증류수 650 ㎕를 넣은 후 Folin-Denis reagent를 50 ㎕ 가하여 3분 동안 실온에서 반응시킨다. 반응시킨 후 10% Na2CO3 포화용액 100 ㎕을 첨가하고, 최종 볼륨을 1mL로 맞추기 위해 증류수 150 ㎕을 넣어 잘 혼합하였다. 37℃ water bath에서 1시간 반응시킨 후 UV-Vis Spectrophotometer(Pharmacia Biotech ultrospec-2000)를 사용하여 725 nm에서 흡광도를 측정하였다. 공시험은 시료 용액 대신 methanol 용액을 동일하게 처리하였으며, 표준곡선은 tannic acid (Sigma Co., USA)의 농도를 0~500 ㎍/mL 이 되도록 하고 이로부터 총 페놀함량을 구하였다.Total polyphenol content was measured by Folin-Denis method. 0.1 g of the extract was dissolved in 10 ml of methanol and diluted to 1 mg / ml. Add 650 μl of distilled water to 50 μl of the sample solution, add 50 μl of Folin-Denis reagent, and allow to react at room temperature for 3 minutes. After the reaction, 100 μl of a saturated solution of 10% Na 2 CO 3 was added, and 150 μl of distilled water was added to adjust the final volume to 1 ml. After reacting in a water bath at 37 ° C for 1 hour, absorbance was measured at 725 nm using a UV-Vis spectrophotometer (Pharmacia Biotech ultrospec-2000). For the blank test, the methanol solution was used instead of the sample solution, and the standard curve was such that the concentration of tannic acid (Sigma Co., USA) was 0 to 500 μg / mL, and the total phenol content was determined therefrom.

폴리페놀계 물질들은 식물체에 특수한 색깔을 부여하고 산화 환원 반응에서 기질로 작용하며 한 분자 내에 2개 이상의 phenolic hydroxyl(OH)기를 가진 방향족 화합물을 가리키며 플라보노이드와 탄닌이 주성분으로 충치예방, 고혈압 억제, 항에이즈, 항산화, 항암 등의 다양한 생리활성을 가진다. 각각의 생약초 에탄올 추출물에 존재하는 총 폴리페놀 함량을 각각 tannic acid을 기준물질로 하여 측정하였다. 배초향에 함유된 폴리페놀 함량은 표 12에 나타낸 바와 같이 51.91 ±4.64 ㎍/ml 이었다.Polyphenolic compounds are aromatic compounds that give a specific color to a plant and act as a substrate in a redox reaction and have two or more phenolic hydroxyl (OH) groups in one molecule. Flavonoids and tannins are the main components. AIDS, antioxidant, and anti-cancer. Total polyphenol contents in each of the herbal extracts were measured using tannic acid as a reference. The content of polyphenol contained in the syrup was 51.91 占 4.64 占 퐂 / ml as shown in Table 12.

Scientific nameScientific name Korean nameKorean name Total phenolics(㎍/ml)Total phenolics (/ / ml) AgastacheAgastache rugosarugosa 배초향Fried 51.91±4.6451.91 + - 4.64

2) 배초향 정유(essential oil)의 항산화 활성 측정2) Determination of antioxidant activity of essential oil

항산화 활성 검색은 DPPH법을 이용하여 시료의 radical 소거 효과를 측정하는 Blois의 방법을 변형하여 측정하였다. 1×10-4M DPPH와 농도별 추출물을 각각 100 ㎕씩 취하여 혼합하고 30분간 암 상태에서 방치한 후 잔존 radical 농도를 ELISA Reader(Bio-RAD, USA)를 이용하여 517nm에서 측정하였다. 시료의 환원력의 크기는 라디칼 소거활성(Scavenging activity)으로 표시하며, RC50은 DPPH 농도가 1/2로 감소하는데 필요한 시료의 양(㎍)으로 나타내었으며 항산화 물질로 잘 알려진 BHT(butylated hydroxytoluene), Vitamin C(ascorbic acid)와 비교하였다. The antioxidant activity was determined by modifying the Blois method to measure the radical scavenging effect of the sample using the DPPH method. 100 μl of 1 × 10 -4 M DPPH and concentration-specific extracts were mixed and left to stand for 30 minutes in darkness. Residual radical concentrations were measured at 517 nm using an ELISA reader (Bio-RAD, USA). The amount of reducing power of the sample is expressed as a scavenging activity. RC 50 is expressed as the amount (μg) of sample required to reduce the concentration of DPPH to 1/2. BHT (butylated hydroxytoluene), which is well known as an antioxidant, Vitamin C (ascorbic acid).

DPPH는 짙은 자색을 띄는 비교적 안정한 free radical로서 방향족 화합물 및 방향족 아민류에 의해 환원되어 탈색되므로 다양한 천연소재로부터 항산화물질을 검색하는데 많이 이용되고 있다. 각 추출물의 항산화 작용을 DPPH법에 의해 측정한 결과는 다음과 같다.DPPH is a relatively stable free radical with a deep purple color. It is often used to search for antioxidants from various natural materials because it is reduced by aromatic compounds and aromatic amines. The antioxidative activity of each extract was measured by the DPPH method as follows.

표 13은 추출물의 DPPH radical 소거에 의한 항산화활성을 DPPH radical 농도를 1/2로 감소하는데 필요한 시료의 양인 RC50 값으로 비교하였으며, 배초향 정유(essential oil)의 RC50 값은 700㎍/㎖로 나타났다. Table 13 were compared with the antioxidant activity by the DPPH radical scavenging of the extract in an amount 50 RC value of a sample required to decrease the DPPH radical concentration to 1/2, RC 50 value of Agastache rugosa essential oil (essential oil) is a 700㎍ / ㎖ appear.

도 12는 배초향 정유(essential oil)의 항산화 활성(Antioxidant activity of extracts from Agastache rugosa)을 나타내고 있다.Fig. 12 shows the antioxidant activity of extract oil from Agastache rugosa.

시 료sample RC RC 50 50 (㎍/ml)(占 퐂 / ml) 배초향(AR)Bleeding (AR) 700700 VitVit C.(ascorbic acid) C. (ascorbic acid) 9.089.08 BHTBHT 95.6895.68

3. 배초향 정유(essential oil)의 항미생물 활성3. Antimicrobial activity of essential oil

배초향의 에탄올 추출 시료 액의 항균 활성을 확인하기 위해 paper disk diffusion 방법을 이용 하였다. 배초향 에탄올 추출물의 결과는 표 14에서 보여지는 것과 같이 4종의 균주에 대하여 강한 항균활성을 나타내었다.The paper disk diffusion method was used to confirm the antimicrobial activity of the ethanol extraction extract solution. As shown in Table 14, the results of the ethanol extracts of the foliar extracts showed strong antimicrobial activity against the four strains.

표 14는 배초향 정유(essential oil)의 항미생물 활성(Antimicrobial activities of ethanol extracts from Agastache rugosa)을 나타내고 있다.Table 14 shows the antimicrobial activities of essential oils from Agastache rugosa.

Strains         Strains Inhibition zone(mm)Inhibition zone (mm) 125㎍/㎖125 [mu] g / ml 250㎍/㎖250 [mu] g / ml 500㎍/㎖500 [mu] g / ml Staphylococcus   Staphylococcus aureusaureus -- ** -- -- Bacillus   Bacillus amyloliquefaciensamyloliquefaciens -- -- -- Enterobacter spp. Enterobacter spp. 2020 3030 5050 ListeriaListeria monocytogenesmonocytogenes 3030 4040 4040 Pityrosporum ovale Pityrosporum oval e 3030 4040 5050 Staphylococcus   Staphylococcus epidermidisepidermidis 2020 2020 3030 CandidaCandida albicamsalbicams -- -- 2020

* : Not detected  *: Not detected

4. 배초향 정유(essential oil)의 항미생물 활성4. Antimicrobial activity of essential oil

Propionibacterium acnes균에 대한 배초향 정유는 30~40%의 농도에서 항균활성을 보였으며, Staphylococcus epidermidis균에 대하여도 30%, 40% 농도에서 강력한 항균 활성을 보였다. 또한 정유 추출물을 10, 20, 30 및 40% 농도별로 Malassezia furfur 에 paper disc agar diffusion 법으로 항균성을 측정한 결과, 40% 농도에서는 배초향 꽃과 배초향 지상부에서 추출된 정유에서 항균활성이 나타났다. Propionibacterium The antimicrobial activity of acnes was 30 ~ 40%, and Staphylococcus epidermidis showed strong antimicrobial activity at 30% and 40% concentration. In addition, essential oil extracts were added to 10, 20, 30 and 40% concentration of Malassezia furfur The antimicrobial activity was measured by paper disc agar diffusion method, and the antimicrobial activity was observed at the concentration of 40%.

도 13 및 표 15는 배초향 정유(essential oil)의 항미생물 활성(Antimicrobial activity of essential oil from herb against Staphylococcus epidermidis. ① 배초향 꽃 ② 배초향 지상부)을 나타내고 있다.Figures 13 and 15 show the antimicrobial activity of essential oil from the herbicide essential oil from herb against Staphylococcus epidermidis .

균 주Bacterium Antimicrobial activity(mm)Antimicrobial activity (mm) 20%20% 30%30% 40%40% Staphylococcus epidermidisStaphylococcus epidermidis 배초향꽃Blossom flower -- ++++++ ++++ 배초향지상부Back ground top -- ++ ++

도 14는 배초향 정유(essential oil)의 농도에 따른 항미생물 활성(Antimicrobial activity of essential oil depending on various concentration against Staphylococcus epidermidis . A 배초향꽃, B 배초향 지상부)을 나타내고 있다.14 shows the essential oil antimicrobial activity Agastache rugosa (Antimicrobial activity of essential oil depending on various concentration against Staphylococcus epidermidis. Flowers Agastache rugosa A, B Agastache rugosa aerial part) according to the concentration of the (essential oil).

시료      sample
농도.density.
A.배초향꽃A. blossom flowers B.배초향 지상부B. Bamboo ground top
Essential oil 5㎕+EtOH 35㎕Essential oil 5 [mu] l + EtOH 35 [ 3.33.3 -- Essential oil 10㎕+EtOH 30㎕Essential oil 10 μl + EtOH 30 μl 3.33.3 -- Essential oil 20㎕+EtOH 20㎕Essential oil 20 [mu] l + EtOH 20 [ 55 33 Essential oil 30㎕+EtOH 10㎕Essential oil 30 [mu] l + EtOH 10 [ 6.36.3 -- Essential oil 40㎕Essential oil 40 μl 8.68.6 2.62.6

도 15는 배초향 정유(essential oil)의 항미생물 활성(Antimicrobial activity of essential oil from herb against Propionibacterium acnes . 1. 배초향 꽃 2. 배초향 지상부)을 나타내고 있다.15 is Agastache rugosa essential oil antimicrobial activity (Antimicrobial activity of (essential oil) of essential oil from herb against Propionibacterium acnes . 1. Blossom bloom 2. Above ground part.

StrainsStrains Antimicrobial activity(mm)Antimicrobial activity (mm) 20%20% 30%30% 40%40% PropionibacteriumPropionibacterium acnesacnes 배초향꽃Blossom flower -- ++ ++ 배초향지상부Back ground top -- ++ ++

도 16은 배초향 정유(essential oil)의 농도에 따른 항미생물 활성(Antimicrobial activity of essential oil depending on various concentration against Propionibacterium acnes)을 나타내고 있다.FIG. 16 shows the antimicrobial activity of essential oil depending on the concentration of essential oil.

시료    sample
농도density
A. 배초향꽃A. blossom flowers B. 배초향 지상부B. Bamboo ground top
Essential oil 5㎕+EtOH 35㎕Essential oil 5 [mu] l + EtOH 35 [ 33 -- Essential oil 10㎕+EtOH 30㎕Essential oil 10 μl + EtOH 30 μl 2.62.6 -- Essential oil 20㎕+EtOH 20㎕Essential oil 20 [mu] l + EtOH 20 [ 3.33.3 22 Essential oil 30㎕+EtOH 10㎕Essential oil 30 [mu] l + EtOH 10 [ 44 2.62.6 Essential oil 40㎕Essential oil 40 μl 4.34.3 3.33.3

* : not available*: not available

도 17은 배초향 정유(essential oil)의 항미생물 활성(Antimicrobial activity of essential oil from herb against Malassezia furfur . 좌측: 배초향 꽃 우측: 배초향 지상부)을 나타내고 있다.FIG. 17 shows the antimicrobial activity of essential oil from herb against Malassezia furfur. Left: bamboo flower right: bamboo ground part).

Sample
Conc.
Sample
Conc.
배초향꽃Blossom flower 배초향 지상부Back ground top
Essential oil 5㎕+EtOH 35㎕Essential oil 5 [mu] l + EtOH 35 [ 4.64.6 -- Essential oil 10㎕+EtOH 30㎕Essential oil 10 μl + EtOH 30 μl 5.35.3 2.32.3 Essential oil 20㎕+EtOH 20㎕Essential oil 20 [mu] l + EtOH 20 [ 5.65.6 2.32.3 Essential oil 30㎕+EtOH 10㎕Essential oil 30 [mu] l + EtOH 10 [ 66 2.62.6 Essential oil 40㎕Essential oil 40 μl 6.36.3 44

상엽The top 및 상백피 And morphine

상백피는 뽕나무과(Moracerae)에 속한 뽕나무의 뿌리껍질이며, 상엽은 뽕나무의 잎으로서, 주 효능으로는 소갈치료효과, 혈당강하, 혈압강하, 항균작용, 소염작용, 당뇨병 예방 및 치료에 이용되고 있으며, 루틴(rutin), 쿼서틴(quercetin), 모라세틴(moracetin), 베타-시토스테롤(b-sitosterol), 캄페스테롤(campesterol), 루페올(lupeol), 미오이노시놀(myoinositol), 이노코스테론(inokosterone) 등과 같은 성분들을 함유하고 있다. 본 명세서에서 상엽 추출물은 상백피 추출물을 포함하는 것으로 한다.The main bark is the root of bark belonging to Moracerae, and the top leaf is the leaf of mulberry. Its main effect is used for the treatment of noise, hypoglycemia, hypotension, antimicrobial action, anti-inflammatory action, prevention and treatment of diabetes, The compounds of the present invention may be used in combination with one or more of the following: rutin, quercetin, moracetin, b-sitosterol, campesterol, lupeol, myoinositol, inokosterone), and the like. In the present specification, the mulberry leaf extract comprises the mulberry bark extract.

1. 구강유해균에 대한 항미생물 활성1. Antimicrobial activity against oral bacteria

열수 추출법으로 조제한 뽕나무 잎과 뽕나무 뿌리 추출물을 시료로하여 paper disc 법을 이용하여 치아우식의 원인균으로 작용하는 Streptococcus mutans에 대한 증식저해능을 분석하였다. S. mutans에 처리한 추출물의 농도는 1, 10, 50, 100 ㎎/㎖ 이며, 실험결과는 상백피(뽕나무 뿌리껍질) 추출물의 경우, 농도의존적으로 균을 저해함을 알 수 있는데 1㎎/㎖에서는 1.5mm, 10㎎/㎖에서 1.8mm, 50㎎/㎖에서 3.2mm, 100㎎/㎖에서 6mm의 저해 투명대를 나타냈으며, 상엽(뽕나무 잎) 추출물에서는 모든 농도군에서 항균활성을 보이지 않았다. Using paper disc method, mulberry leaf and mulberry root extracts prepared by hot water extraction method were used to analyze the inhibitory effect of Streptococcus mutans acting as a causative organism of dental caries. The concentrations of extracts treated with S. mutans were 1, 10, 50, and 100 ㎎ / ㎖, and the results showed that the extracts of mulberry root (mulberry root shell) Inhibition of the antimicrobial activity of the mulberry leaf extracts was not observed in all concentration groups.

도 18 및 표 20은 상엽 추출물(좌측)과 상백피 추출물(우측)의 항균활성 결과를 나타내고 있다.18 and 20 show the antimicrobial activity results of the extracts of the upper leaves (left side) and the extract of the mulberry bark (right side).

시료 농도 (mg/mL)Sample concentration (mg / mL) 상엽The top 상백피Mallow Clear zone (mm)Clear zone (mm) 1One -- 1.51.5 1010 -- 1.81.8 5050 1.31.3 3.23.2 100100 1.61.6 66

또한, 상엽의 경우, 6종의 구강질환 유발균에 대하여 살균력의 최소농도를 분석한 결과, 3종의 균에 대하여 탁월한 치사력을 나타내었다.In addition, in the case of the upper leaves, the minimum concentration of sterilization power was analyzed for six kinds of oral disease causing bacteria, and it showed excellent lethal power against three kinds of bacteria.

표 21은 상엽 추출물의 최소살균농도(Minimum bactericidal concentration of extracts from Morus alba L. leaves)를 나타내고 있다.Table 21 shows the minimum bactericidal concentration of extracts from Morus alba L. leaves.

MBC (mg/mL)MBC (mg / mL) Aa 33384 Aa 33384 Tf 43037Tf 43037 Fn 25586Fn 25586 Pi 25611Pi 25611 Pg 33277Pg 33277 Sm 25175Sm 25175 >2> 2 0.50.5 0.1250.125 0.1250.125 <0.015<0.015 >2> 2

* Aa 33384 : Actinobacillus actinomycetem - comitans (침습성 치주염, 잇몸질환 유발균)* Aa 33384: Actinobacillus actinomycetem - comitans (invasive periodontitis, gum disease causing bacteria)

* Tf 43037 : Tannerella forsythensis (치주염 유발균)* Tf 43037: Tannerella forsythensis

* Fn 25586 : Fusobacterium necrophorum (궤양성 구내염, 치주질환, 구취의 원인균)* Fn 25586: Fusobacterium necrophorum (ulcerative stomatitis, periodontal disease, causing bad breath)

* Pi 25611 : Prevotella intermedia (호르몬 관련 치주염 유발균)* Pi 25611: Prevotella intermedia (hormone-related periodontitis causing bacteria)

* Pg 33277 : Porphyromonas gingivalis (치주질환의 주요 원인균종)* Pg 33277: Porphyromonas gingivalis (major causative agent of periodontal disease)

* Sm 25175 : Streptococcus mutans (치아우식증의 주요 원인균종) * Sm 25175: Streptococcus mutans (a major cause of dental caries)

II. 치약II. toothpaste 조성물의 제조 Preparation of composition

1. 합성원료의 치약과 천연원료의 치약성분의 차이1. Difference between toothpaste of synthetic raw material and toothpaste ingredient of natural raw material

통상 합성원료로 구성된 구강용 조성물중 하나인 치약의 구성성분은 합성 연마제, 합성 습윤제, 합성 기능성원료, 인공착색제 및 착향제, 그리고 세제용 기포제 등을 포함한다. The components of toothpaste, which is usually one of the oral compositions composed of synthetic raw materials, include synthetic abrasives, synthetic humectants, synthetic functional raw materials, artificial coloring and flavoring agents, and foaming agents for detergents.

한편, 천연원료로 구성된 구강용 조성물중 하나인 치약의 구성성분은 천연 연마제, 천연 습윤제, 기능성원료(편백, 허브류 등), 식물성 착색제 및 착향제, 그리고 천연 기포제 등을 포함한다.On the other hand, the constituents of toothpaste which is one of the oral compositions composed of natural raw materials include natural abrasives, natural wetting agents, functional raw materials (plain white, herbal etc.), vegetable coloring agents and flavoring agents, and natural foaming agents.

2. 조성물 성분의 특성 및 기능 2. Characteristics and Function of Composition Component

조성물 성분의 특성 및 기능을 아래 [표 22]에 나타낸다.The properties and functions of the composition components are shown in Table 22 below.

성 분ingredient 특성 및 기능Features and Functions 습윤제Wetting agent 크림형 세치제의 굳는 현상 방지Preventing the hardening of the cream type cuticle 주성분chief ingredient 충치예방, 치주질환 예방 & 항산화작용 (Vitamin B6),
치석침착예방
Prevention of tooth decay, prevention of periodontal disease & antioxidant effect (Vitamin B6),
Prevention of calcification
연마제abrasive 치태제거Removal of plaque 점도 조절제Viscosity modifier 조성물의 전체적인 점도를 조절Adjust the overall viscosity of the composition 증백제Brighteners 추출물의 색상 조정 및 조성물의 증백화에 의해 추출물에
의한 치아의 착색방지
By adjusting the color of the extract and increasing the composition,
Prevention of tooth discoloration by tooth
부형제
(hydroxyapatite)
Excipient
(hydroxyapatite)
인간의 뼈와 주성분이 같은 세라믹으로, 인공 뼈, 치근으로 이용되며, 생체 적응성이 양호하여 조직과의 일체화가 가능함.It is the same ceramic as human bone and main component, it is used as artificial bone and root, and it is possible to integrate with tissue with good bio-adaptability.
감미제Sweetener 감미도가 설탕의 약 100~200배인 감미료로 치약의 향이나 맛을 조정함Adjusts the flavor and taste of the toothpaste with a sweetener whose sweetness is about 100 to 200 times that of sugar 기포제Foaming agent 서로 잘 혼합되지 않는 액체나 고체를 액체에 균일하게 분산시키기 위해 사용되는 첨가물로 거품을 유발시켜 양치질감을 상승시키며, 더러운 물질을 제거, 세정하는 기능It is an additive used to uniformly disperse a liquid or solid that does not mix with each other uniformly in a liquid. It causes bubbles to increase the feeling of brushing and removes dirty substances.

3. 세치제의 국가별 사용성분 현황3. Status of used ingredients by country

세치제의 국가별 사용 성분을 아래 [표 23]에 나타낸다.[Table 23] shows the ingredients used in each country of Sekishi.

국가별 사용성분
분류
Ingredient used by country
Classification
국내
(표준제조기준)
domestic
(Standard manufacturing standard)
일본
(표준제조기준)
Japan
(Standard manufacturing standard)
미국
(FDA approved)
United States of America
(FDA approved)
치태제거Removal of plaque 인산수소칼슘,무수인산수소칼슘,침강탄산칼슘,탄산칼슘,인산삼칼슘,콜로이드성이산화규소,이산화규소, 무수인산칼슘,함수이산화규소,덴탈타입실리카Calcium hydrogen phosphate, anhydrous calcium hydrogen phosphate, precipitated calcium carbonate, calcium carbonate, tricalcium phosphate, colloidal silicon dioxide, silicon dioxide, anhydrous calcium phosphate, hydrated silicon dioxide, dental type silica 유효성분으로
인정하지 않음
As an active ingredient
Do not accept
유효성분으로
인정하지 않음
As an active ingredient
Do not accept
잇몸질환예방Gum disease prevention 염화나트륨,토코페롤아세테이트,피리독신염산염,알란토인,알란토인클로로히드록시알루미늄,트라넥사민산,아미노카프론산Sodium chloride, tocopherol acetate, pyridoxine hydrochloride, allantoin, allantoin chlorohydroxyaluminum, tranexamic acid, aminocaproic acid 염화나트륨,토코페롤아세테이트,피리독신염산염,알란토인클로로히드록시알루미늄,염산클로로헥시딘,염화리소지움,히노키티올,폴리옥시에틸렌라우릴레이트,염화세틸피리디늄,트리클로로산 등 Sodium chloride, tocopherol acetate, pyridoxine hydrochloride, allantoin chlorohydroxy aluminum, chlorohexidine hydrochloride, lysozyme chloride, hinokitiol, polyoxyethylene laurelate, cetylpyridinium chloride, trichloroacid, etc. TriclosanTriclosan 치석침착예방Prevention of calcification 피로인산나트륨Sodium pyrophosphate 제올라이트,
피로인산나트륨,
폴리인산나트륨 등
Zeolite,
Sodium pyrophosphate,
Sodium polyphosphate, etc.
충치예방Caries prevention NaF, SnF, SMFP, AmFNaF, SnF, SMFP, AmF NaF, SnF, SMFP, AmFNaF, SnF, SMFP, AmF 시린이 완화Cyrin relieves KNO₃KNO₃ 담배 타르의 제거Removal of cigarette tar 폴리인산나트륨,
폴리에틸렌글리콜,
폴리비닐피롤리돈
Sodium polyphosphate,
Polyethylene glycol,
Polyvinylpyrrolidone

3. 구강용 조성물의 기능별 첨가성분 및 첨가량3. Functional ingredients and amount of addition of oral composition

구강용 조성물을 이용하여 치약을 제조하기 위해, 동백나무 잎으로부터 추출된 추출물과 함께 조성물의 기본 첨가물로 습윤제, 주성분, 연마제, 점도조절제, 증백제, 부형제, 감미제 중 적어도 하나를 추가할 수 있다. In order to prepare the toothpaste using the oral composition, at least one of a wetting agent, a main ingredient, an abrasive, a viscosity controlling agent, a brightening agent, an excipient and a sweetening agent may be added as a basic additive of the composition together with the extract extracted from the camellia leaves.

전술한 바와 같이 본 발명의 동백나무 잎으로부터 추출된 추출물을 주요 소재로 한 세치제 조성물은, 동백나무 잎으로부터 추출된 추출물 1~4중량%, 배초향 정유(essential oil) 0.001~0.010중량%, 산수유 추출물 0.001~0.010중량%, 인동초 추출물 0.001~0.010중량%, 상엽추출물 0.20~0.80중량%, 효소처리 스테비아(Enzymatically Modified Stevia Glucosyl Stevia) 0.25~0.50중량%, 자일리톨 0.10~0.50중량%, D-소르비톨액 40~60중량%, 덴탈타입실리카 15중량%, 플루오르화나트륨 0.22중량%, 피리독신염산염 0.05중량%, 피로인산나트륨 0.50중량%, 식물성 글리세린 2~3중량%, 하이드록시 아파타이트 0.05중량%, 정제수 12.58~30중량%를 혼합 조성할 수 있다. As described above, the detergent composition comprising the extract extracted from the camellia leaves of the present invention as a main material comprises 1 to 4% by weight of an extract extracted from camellia leaves, 0.001 to 0.010% by weight of essential oil, 0.001 to 0.010% by weight of the extract, 0.001 to 0.010% by weight of the extract of Oriental herbal extract, 0.20 to 0.80% by weight of the leaf extract, 0.25 to 0.50% by weight of Enzymatically Modified Stevia Glucosyl Stevia, 0.10 to 0.50% by weight of xylitol, 40 to 60 wt%, dental type silica 15 wt%, sodium fluoride 0.22 wt%, pyridoxine hydrochloride 0.05 wt%, sodium pyrophosphate 0.50 wt%, vegetable glycerin 2 to 3 wt%, hydroxyapatite 0.05 wt%, purified water 12.58 By weight to 30% by weight.

예를 들어 동백나무 잎으로부터 추출된 추출물 및 기본 성분들의 첨가량에 따른 물성차이를 분석하여 각 성분들의 첨가량을 표 24와 같이 결정할 수 있다.For example, the difference in the physical properties depending on the addition amount of the extract and the basic components extracted from the camellia leaves can be analyzed and the addition amounts of the respective components can be determined as shown in Table 24.

원료명Raw material name 함량(중량%)Content (% by weight) 배합목적Purpose of blending 동백나무 잎으로부터 추출된 추출물Extracts from camellia leaves 1.0~4.01.0 to 4.0 주 효능성분(치은염, 구강유해균 억제, 항산화활성, 구취개선, 치통 및 잇몸궤양 및 구강질환 개선, 항염) Main active ingredients (gingivitis, inhibition of oral bacteria, antioxidant activity, improvement of bad breath, improvement of toothache and gingival ulcer and oral disease, anti-inflammation) 배초향 정유(essential oil)Essential oil 0.001~0.0500.001 to 0.050 산수유 추출물Corn oil extract 0.001~0.0500.001 to 0.050 인동초 추출물Ginseng extract 0.001~0.0500.001 to 0.050 상엽 추출물Leaf extract 0.20~0.800.20 to 0.80 D-소르비톨액D-sorbitol solution 40~6040 to 60 습윤제Wetting agent 식물성 글리세린Vegetable glycerin 2.0~3.02.0 to 3.0 애플워시Apple Wash 2.0~10.02.0 to 10.0 천연 기포제(식물성 계면활성제)Natural foaming agent (vegetable surfactant) 덴탈타입실리카Dental type silica 1515 연마제abrasive 플루오르화나트륨
(불화나트륨)
Sodium fluoride
(Sodium fluoride)
0.220.22 충치예방Caries prevention
피로인산나트륨Sodium pyrophosphate 0.500.50 치석침착예방Prevention of calcification 하이드록시
아파타이트
Hydroxy
Apatite
0.050.05 부형제Excipient
효소처리스테비아Enzyme treatment Stevia 0.25~0.500.25-0.50 감미제Sweetener 자일리톨Xylitol 0.10~0.500.10 to 0.50 정제수Purified water To 100To 100

상기 표 24를 통해 알 수 있는 바와 같이 본 발명의 일 실시예 따른 구강용 조성물은 용제인 정제수에 습윤제로 D-소르비톨액 및 (농)글리세린을, 주성분으로 덴탈타입 실리카 및 플루오르화나트륨(불화나트륨), 피리독신염산염, 피로인산나트륨을, 연마제로 PEG-1500 및 산화티탄을, 점도조절제로 함수규산을, 증백제로 하이드록시아파타이트를, 부형제로 효소로 처리된 스테비아를, 감미제로 자일리톨을 추가로 포함하나 이제 제한되는 것은 아니다. 현편, 구강용 조성물은 기포제로 SLS, 점도조절제로 CMS, 착향제로 옵타민트295901 및 L-멘톨을 포함할 수 있다.As can be seen from Table 24, the oral composition according to one embodiment of the present invention contains D-sorbitol liquid and (concentrated) glycerin as a wetting agent in purified water as a solvent, dental type silica and sodium fluoride (sodium fluoride ), Pyridoxine hydrochloride and sodium pyrophosphate, PEG-1500 and titanium oxide as an abrasive, hydrated silicic acid as a viscosity regulator, hydroxyapatite as a brightener, stevia treated with an enzyme as an excipient, xylitol as a sweetener, But is not limited to these. The mouthpiece composition may contain SLS as a foaming agent, CMS as a viscosity modifier, Optamint 295901 as a flavoring agent, and L-menthol.

III. 임상실험III. Clinical experiment

본 명세서는 동백추출물 함유 구강용 조성물의 항치태효과, 항치은염 효과, 구강 내 미생물 감소효과를 임상실험연구를 통해서 평가하고자 하였다.The present invention aims to evaluate the anti-stinging effect, anti-gingivitis effect and oral microbial reduction effect of oral composition containing camellia extract through clinical experimental studies.

1. 임상연구 대상1. Clinical research subjects

본 명세서는 조선대학교 치과병원의 연구윤리심의위원회의 승인을 받은 연구로써, 모든 대상자는 임상시험연구에 자발적으로 동의한 자로 한정하였다. 현존 자연치아수가 최소 18개 이상인 20-59세 성인 남녀를 대상으로 하였다. 치면세균막 억제효과를 평가하기 위하여 치면세균막이 축적되어 있다고 판단되는(Patient Hygiene Performance; PHP Index 값이 1.5 이상)자 만을 대상으로 하였다. This study was approved by the Research Ethics Review Committee of Chosun University Dental Hospital and all subjects were limited to those who voluntarily agreed to participate in clinical trial research. The subjects were 20-59 year old adults with at least 18 natural teeth. (Patient Hygiene Performance; PHP Index: 1.5 or higher), which is thought to accumulate dental plaque.

기존 국내 연구결과에서 치은염 감소 유효물질(탄산수소나트륨 함유치약) 사용군의 치면세균막 감소량과 대조군의 효과크기(effect size)를 산출하였다. 두 연구에서 각각 계산한 효과크기의 평균을 산출하였고, 이를 Z분포의 검정력(Zα=0.05, Zβ=0.2, 단측검증)을 고려하여 초기 목표 표본 수를 각 군당 25명으로 산정하였다. 또한 4주간의 연구기간을 고려하여 탈락률을 10%로 결정하여 최종 연구대상자는 82명으로 정하였다.In the results of the existing domestic studies, the reduction effect of the dental plaque membrane and the effect size of the control group were calculated in the group using the gingivitis reduction effective substance (sodium hydrogencarbonate-containing toothpaste). We calculated the average size of each effect in both studies, and the number of initial target samples was calculated as 25 for each group considering the power of Z distribution (Zα = 0.05, Zβ = 0.2, unilateral verification). In addition, considering the 4 - week study period, the dropout rate was determined as 10% and the final study subjects were 82.

최종 연구대상자를 치약 군별로 이중맹검무작위(double Blinded Randomization)로 배정하였고 각 치약 군에 배정된 연구대상자의 성, 연령, 치면세균막지수는 통계적으로 유의한 차이 없이 고르게 분포하였다(p>0.05, 표 25). The final study subjects were assigned to double-blind randomization by toothpaste group, and the sex, age, and dental flora of the subjects assigned to each tooth group were evenly distributed without statistically significant difference (p> 0.05, 25).

본 임상시험연구에 사용한 치약은 동백나무 잎으로부터 추출된 추출물이 전혀 포함되어 있지 않는 음성 대조군 치약군(치약 ‘가’ 군), 동백나무 잎으로부터 추출된 추출물이 포함되어 있는 치약군(치약 ‘나’ 군), 치은염개선 효과가 밝혀진 상용치약군(시판제품 ‘안티프라그’)으로 총 3개 군을 비교 평가하였다.The toothpaste used in this study was a negative control group (toothpaste 'group') containing no extracts extracted from camellia leaves, a toothpaste group containing extracts extracted from camellia leaves , And commercial toothpaste (anti - plaque product), which showed the improvement of gingivitis.

구분division 치약 가군Toothpaste. 치약 나군Toothpaste. 안티프라그Anti-plague p-valuep-value 연구대상자수(명)Study subjects (persons) 24(34.3)24 (34.3) 24(34.3)24 (34.3) 22(31.4)22 (31.4) 성별(%)* Gender (%) * 남자man 5(20.8)5 (20.8) 10(41.7)10 (41.7) 11(50.0)11 (50.0) 0.10* 0.10 * 여자Woman 19(79.2)19 (79.2) 14(58.3)14 (58.3) 11(50.0)11 (50.0) 연령(Mean±sd)Age (Mean ± sd) 30.65±2.1930.65 ± 2.19 30.17±2.1430.17 ± 2.14 31.86±2.4631.86 + - 2.46 0.62** 0.62 ** PHP IndexPHP Index 1.76±0.161.76 + 0.16 1.72±0.121.72 + - 0.12 1.87±0.131.87 + - 0.13 0.56** 0.56 ** *Chi-squre test * Chi-square test **One-way ANOVA ** One-way ANOVA

본 연구는 실제 연구기간 4주 및 연구 준비 및 정리기간을 포함해서 총 6개월간 진행되었다. 검사자는 연구대상자가 처음 내원 시 구강검사를 하여 연구적합 대상자 여부를 판단하여 82명의 적합 대상자를 선정하였다. 모든 피험자는 구강위생 교육을 받고, 연구기간 동안 칫솔질을 하루 두 번 이상, 본인의 습관대로 하도록 지시하였다. 단 구강 양치액의 사용은 제한하였다  This study was conducted for a total of 6 months including 4 weeks of actual research period and research preparation and preparation period. The examiner selected 82 eligible subjects by judging whether or not they were eligible for the study by oral examination at the first visit. All subjects were instructed to take oral hygiene training and to brush their teeth twice a day or more during the study period according to their habits. The use of oral mouthrinse was limited

내용Contents 1차Primary 2차Secondary 3차Third 기간term 0일0 days 2주2 weeks 4주4 weeks 평가evaluation Base-line
타액검사
치은염평가
항치태평가
Base-line
Saliva test
Gingivitis evaluation
Term evaluation
타액검사
치은염평가
항치태평가
Saliva test
Gingivitis evaluation
Term evaluation
타액검사
치은염평가
항치태평가
Saliva test
Gingivitis evaluation
Term evaluation
참여대상자Participants 82명82 people 70명70 people 70명70 people

2. 임상평가2. Clinical evaluation

피험자는 매 내원 마다 타액검사, 치은염지수 평가, 치태지수평가의 순으로 임상 평가를 받았다.Subjects were evaluated clinically by saliva test, gingivitis index, and plaque index.

1) 타액검사1) Saliva test

먼저 피험자를 대상으로 파라핀왁스를 씹으면서 자극성 타액을 발생 시킨 후 타액 채취는 baseline, 2주후 및 4주후, 총 3번에 걸쳐서 측정하였다.First, the subjects were asked to chew paraffin wax to generate irritating saliva, and then saliva was collected three times, baseline, two weeks, and four weeks later.

2) 치은염 평가2) Evaluation of gingivitis

치은염 평가를 위하여 본 연구에서는 Le & Silness Gingival index를 이용하였다. 이 평가법에서는 index 치아로서 상악 우측 제 1대구치, 상악 우측 제 2전치, 상악 좌측 제 1 소구치, 하악 좌측 제 1대구치, 하악 좌측 제 2전치, 하악 우측 제 1소구치를 대상으로 한다.For the evaluation of gingivitis, the Le & Silness Gingival index was used in this study. In this evaluation method, the teeth in the upper right maxillary first molar, the maxillary right second incisor, the maxillary left first molar, the mandibular left first molar, the mandibular left second incisor, and the mandibular first premolar are used as index teeth.

3) 치태 지수 평가3) Evaluation of plaque index

본 명세서에서는 치태 평가 지수로 PHP (Patient Hygiene Performance, PHP) Index를 이용하였다. In this specification, the PHP (Patient Hygiene Performance, PHP) Index was used as the plaque index.

3. 통계분석3. Statistical Analysis

각 군별 치면세균막지수는 Kolmogorov-Smirnov test를 통해 정규분포성을 확인한 후 분석하였다. 각 세가지 실험군의 치약사용 기간 경과에 따라 타액 내 Streptococcus mutans 수의 변화, 치은염 지수의 변화, 치면세균막의 변화가 있는지를 검정하기 위해 반복 측정된 분산분석(Repeated measure ANOVA)을 시행하고, 군간 유의차 검정을 위해서 일요인 분산분석(ANOVA)을 실행한 수 군간 유의차는 Duncan’s 다중 비교법을 이용하여 사후 검정을 하였다. 각 실험군 별로 치약사용 전과 후의 평균 차이를 비교하기 위해 대응표본T검정(Paired t-test)을 하였다. 통계분석은 SPSS 18.0 통계 패키지 프로그램(SPSS Inc., U.S.A.)을 이용하였으며 유의수준은 0.05로 하였다.The dental plaque indexes of each group were analyzed by Kolmogorov-Smirnov test. Repeated measure ANOVA was performed to determine whether there was a change in the number of Streptococcus mutans in the saliva, changes in the gingival index, and changes in the dental plaque membrane according to the duration of toothpaste use in each of the three experimental groups. Duncan's multiple comparison method was used for the post-test to determine the significant difference between the groups performing the ANOVA. A Paired t-test was used to compare the mean difference between before and after toothpaste use for each experimental group. Statistical analysis was performed using the SPSS 18.0 statistical package program (SPSS Inc., U.S.A.) with a significance level of 0.05.

4. 연구 결과4. Research Results

1) 치은염 감소효과1) Gingivitis reduction effect

표 27을 통해 알 수 있는 바와 같이, 치약 ‘가’군, 치약‘나’군, 안티프라그군에서 사용 후 시간이 지남에 따라 치은염 지수가 감소하였다. 그러나 치약 사용 군별로 치은염 지수의 감소가 보이는 것은 아니었다(p>0.05). 치약‘가’군과 치약 ‘나’군의 경우 사용 2주후, 4주후 지속적으로 치은염 감소에 영향을 미치는 것으로 나타났다(p<0.05). 치약 ‘가’군의 경우 안티프라그 군과 비교하여 치은염 감소가 1.1배, 치약‘나’군의 경우 1.5배 있었다. As can be seen from Table 27, the gingival index decreased with time after use in toothpaste, toothpaste, toothpaste, and anti-prage group. However, there was no decrease in the gingivitis index (p> 0.05). Toothpaste ',' group ',' toothpaste ', and' army 'group showed continuous decrease of gingivitis after 2 weeks and 4 weeks (p <0.05). In the case of toothpaste 'A', the reduction in gingivitis was 1.1 times and 1.5 times in the case of toothpaste 'I', respectively.

구분 및 측정시기Classification and measurement timing 평균차이
(MD±SE)
Average difference
(MD + SE)
p-value* p-value * p-value** p-value **
0일0 days 2주 후after 2 weeks 4주 후After 4 weeks 치약 가군Toothpaste. 1.60±0.061.60 + 0.06 1.43±0.061.43 + 0.06 -- 0.17±0.050.17 ± 0.05 0.00* 0.00 * <0.001** <0.001 ** -- 1.43±0.061.43 + 0.06 1.31±0.071.31 + 0.07 0.13±0.040.13 + 0.04 0.01* 0.01 * 1.60±0.061.60 + 0.06 -- 1.31±0.071.31 + 0.07 0.29±0.270.29 ± 0.27 0.00* 0.00 * 치약 나군Toothpaste. 1.61±0.061.61 + 0.06 1.38±0.061.38 + 0.06 -- 0.24±0.050.24 ± 0.05 0.00* 0.00 * -- 1.38±0.061.38 + 0.06 1.22±0.061.22 + 0.06 0.16±0.050.16 ± 0.05 0.00* 0.00 * 1.61±0.061.61 + 0.06 -- 1.22±0.061.22 + 0.06 0.40±0.050.40 ± 0.05 0.00* 0.00 * 안티프라그Anti-plague 1.58±0.071.58 + 0.07 1.42±0.061.42 ± 0.06 -- 0.17±0.040.17 + 0.04 0.01* 0.01 * -- 1.42±0.061.42 ± 0.06 1.33±0.071.33 + 0.07 0.09±0.050.09 ± 0.05 0.100.10 1.58±0.071.58 + 0.07 -- 1.33±0.071.33 + 0.07 0.26±0.040.26 + 0.04 0.070.07 *p<0.05 obtained by paired t-test * p < 0.05 obtained by paired t-test **p<0.05 obtained by Repeated measure ANOVA ** p <0.05 obtained by Repeated measure ANOVA MD±E denote Mean difference±standard errorMD ± E denote Mean difference ± standard error

2) 치면세균막 형성 억제 효과2) Inhibitory effect of bacterial membrane formation on tooth surface

표 28을 통해 알 수 있는 바와 같이, 치약 ‘가’군, 치약‘나’군, 안티프라그군에서 사용 후 시간이 지남에 따라 치면세균막 지수가 감소하였다. As can be seen from Table 28, when the toothpaste was applied to the group, the toothpaste, the army, and the anti-prage group, the bacterial film index decreased after the use time.

그러나 치약 사용 군별로 치면세균막 지수의 감소 차이를 보이는 것은 아니었다(p>0.05). 치약‘나’군의 경우 사용 2주 후 치면세균막이 통계적으로 유의하게 감소하였고, 4주까지 유지되는 것으로 나타났다(p<0.05). However, there was no significant difference in the reduction of dental floss (p> 0.05). In the case of toothpaste 'I', the bacterial membrane was statistically decreased after 2 weeks of use and maintained for 4 weeks (p <0.05).

그러나 치약‘가’군의 경우 치면세균막 지수가 감소하긴 하였으나 그 값이 통계적으로 유의하지 않았다(p>0.05).However, in the case of tooth group 'A', the bacterial count index decreased, but the value was not statistically significant (p> 0.05).

구분 및 측정시기Classification and measurement timing 평균차이
(MD±SE)
Average difference
(MD + SE)
p-value* p-value * p-value** p-value **
0일0 days 2주 후after 2 weeks 4주 후After 4 weeks 치약 가군Toothpaste. 1.74±0.121.74 + - 0.12 1.57±0.141.57 + - 0.14 -- 0.17±0.140.17 + 0.14 0.220.22 <0.001** <0.001 ** -- 1.57±0.141.57 + - 0.14 1.49±0.121.49 ± 0.12 0.08±0.120.08 ± 0.12 0.530.53 1.74±0.121.74 + - 0.12 -- 1.49±0.121.49 ± 0.12 0.25±0.130.25 + 0.13 0.070.07 치약 나군Toothpaste. 1.76±0.161.76 + 0.16 1.51±0.161.51 ± 0.16 -- 0.24±0.100.24 0.10 0.03* 0.03 * -- 1.51±0.161.51 ± 0.16 1.49±0.191.49 ± 0.19 0.02±0.090.02 0.09 0.810.81 1.76±0.161.76 + 0.16 -- 1.49±0.191.49 ± 0.19 0.26±0.120.26 ± 0.12 0.04* 0.04 * 안티프라그Anti-plague 1.87±0.131.87 + - 0.13 1.58±0.181.58 ± 0.18 -- 0.28±0.150.28 ± 0.15 0.070.07 -- 1.58±0.181.58 ± 0.18 1.62±0.161.62 ± 0.16 -0.04±0.12-0.04 ± 0.12 0.760.76 1.87±0.131.87 + - 0.13 -- 1.62±0.161.62 ± 0.16 0.24±0.110.24 0.11 0.03* 0.03 * *p<0.05 obtained by paired t-test * p < 0.05 obtained by paired t-test **p<0.05 obtained by Repeated measure ANOVA ** p <0.05 obtained by Repeated measure ANOVA MD±E denote Mean difference±standard errorMD ± E denote Mean difference ± standard error

본 발명에 의하면, 구강용 조성물로써 치약 조성물에 치은염 개선, 항산화활성, 구강유해균의 억제 및 살균, 치석개선능을 주요 효능으로 가지고 있는 동백나무 잎으로부터 추출된 추출물과 배초향 정유(essential oil), 산수유 추출물, 인동초 추출물, 상엽 추출물을 첨가하므로서 이들 천연물을 함유한 조성물이 다양한 구강질환을 개선할 수 있는, 특히, 임상시험의 결과로 검증된 치은염 및 치주질환 개선과 치료효과가 있음을 밝혀졌다. According to the present invention, it is possible to provide a dentifrice composition, which is an oral composition, which contains gypsum salts, antioxidative activity, inhibition and sterilization of oral noxious bacteria, and extract of camellia leaves, essential oils, It has been found that the composition containing these natural substances can improve various oral diseases by adding extracts, ginseng extracts, and leaf extracts, and in particular, has proven gingivitis and periodontal disease improvement and therapeutic effects as a result of clinical trials.

또한 본 발명에 의하면, 구강용 조성물로써 치약조성물은 치약의 색상이 유지되고 향이 변화되더라도 치약에 함유된 약효제의 효과가 유지되고 사용 시 상쾌함을 주는 효과가 있다.According to the present invention, the dentifrice composition as an oral composition has the effect of maintaining the effect of the medicinal effect contained in the dentifrice even when the color of the dentifrice is maintained and the fragrance thereof is changed, and it is refreshing when used.

V. 다른V. Other 구강용 조성물의 제조 Manufacture of oral composition

전술한 치약 조성물 이외에 구강청결제 (구강세정제)의 조성물, 구강향수의 조성물, 의치세정제의 조성물, 이쑤시게 코팅용 조성물, 치실 코팅용 조성물, 구강용 필름 조성물, 잇몸 보호용 젤 조성물 등 구강용 조성물은 제형의 종류와 목적에 따라서 성분간의 배합비는 약간 달라질 수 있으나 기본적인 성분은 상기한 조성물의 성분들에 준하여 적용한다.In addition to the dentifrice composition described above, the oral composition such as a composition of oral cleanser (oral cleanser), a composition of oral perfume, a composition of dentifrice cleanser, a composition for toothpick coating, a composition for dental coating, a composition for oral film, Depending on the type and purpose, the compounding ratio between the components may be slightly different, but the basic components are applied in accordance with the components of the above composition.

전술한 바와 같이 구강용 조성물로은 동백나무 잎으로부터 추출한 추출물 1~4중량%, 배초향 정유(essential oil) 0.001~0.010중량%, 산수유 추출물 0.001~0.010중량%, 인동초 추출물 0.001~0.010중량%, 상엽추출물 0.20~0.80중량%를 포함하며, 제형의 종류와 목적에 따라서, 습윤제, 천연기포제, pH 조절제, 충치예방, 식용 착향제, 천연 보존제, 산포제, 유화제, 감미제, 제 등을 추가로 포함할 수 있다.As described above, the composition for oral cavity comprises 1 to 4% by weight of the extract extracted from the camellia leaves, 0.001 to 0.010% by weight of essential oil, 0.001 to 0.010% by weight of the extract of corn oil, 0.001 to 0.010% The composition may further contain 0.20 to 0.80 wt% of a wetting agent, a natural foaming agent, a pH adjusting agent, a tooth decay prevention agent, an edible flavoring agent, a natural preservative, a dispersing agent, an emulsifying agent, a sweetening agent, and the like depending on the type and purpose of the formulation have.

아래에서 예시적으로 구강 조성물의 성분비 및 배합 목적을 설명하나 본 발명은 이에 제한되지 않는다.The ingredient ratio and the purpose of compounding of the oral composition will be described below by way of example, but the present invention is not limited thereto.

1. 구강청결제 (구강세정제)의 조성물1. Composition of Oral Cleanser (Oral Cleanser)

원료명Raw material name 함량(content( 중량%weight% )) 배합목적Purpose of blending 동백잎 추출물Camellia leaf extract 1.0~4.01.0 to 4.0 주 효능성분(치은염, 구강유해균 억제, 항산화활성, 구취개선, 치통 및 잇몸궤양 및 구강질환 개선, 항염) Main active ingredients (gingivitis, inhibition of oral bacteria, antioxidant activity, improvement of bad breath, improvement of toothache and gingival ulcer and oral disease, anti-inflammation) 배초향 정유Refined oil 0.001~0.0500.001 to 0.050 산수유 추출물Corn oil extract 0.001~0.0500.001 to 0.050 인동초 추출물Ginseng extract 0.001~0.0500.001 to 0.050 상엽 추출물Leaf extract 0.20~0.800.20 to 0.80 D-소르비톨액D-sorbitol solution 40~6040 to 60 습윤제Wetting agent 식물성 글리세린Vegetable glycerin 2.0~3.02.0 to 3.0 코코베타인Coco Betaine 2.0~10.02.0 to 10.0 천연 기포제(코코넛 유래 식물성 천연 계면활성제)Natural foaming agent (natural surfactant derived from coconut) 구연산(수화물)Citric acid (hydrate) 0.0050.005 pH 조절제pH adjusting agent 플루오르화나트륨
(불화나트륨)
Sodium fluoride
(Sodium fluoride)
0.220.22 충치예방Caries prevention
민트향(mint scent)Mint scent 0.200.20 식용 착향제Edible flavoring agent 자몽씨 추출물Grapefruit seed extract 0.200.20 천연 보존제Natural preservative 효소처리스테비아Enzyme treatment Stevia 0.25~0.500.25-0.50 감미제Sweetener 자일리톨Xylitol 0.10~0.500.10 to 0.50 정제수Purified water To 100To 100

민트향(mint scent)은 식용 착향제로 민트향을 내는 어떤 재료라도 무방하다. A mint scent is any flavoring agent that can impart a mint flavor.

2. 구강향수의 조성물
2. Composition of oral perfume

원료명Raw material name 함량(content( 중량%weight% )) 배합목적Purpose of blending 동백잎 추출물Camellia leaf extract 0.2~1.00.2 to 1.0 주 효능성분(치은염, 구강유해균 억제, 항산화활성, 구취개선, 치통 및 잇몸궤양 및 구강질환 개선, 항염) Main active ingredients (gingivitis, inhibition of oral bacteria, antioxidant activity, improvement of bad breath, improvement of toothache and gingival ulcer and oral disease, anti-inflammation) 배초향 정유Refined oil 0.001~0.0500.001 to 0.050 산수유 추출물Corn oil extract 0.001~0.0500.001 to 0.050 인동초 추출물Ginseng extract 0.001~0.0500.001 to 0.050 상엽 추출물Leaf extract 0.20~0.800.20 to 0.80 D-소르비톨액D-sorbitol solution 10.0010.00 습윤제Wetting agent 식물성 글리세린Vegetable glycerin 2.0~3.02.0 to 3.0 코코넛오일Coconut oil 0.100.10 천연 계면활성제Natural surfactant 구연산(수화물)Citric acid (hydrate) 0.0050.005 pH 조절제pH adjusting agent 베이킹소다Baking soda 프라그 제거, 미백효과, 구취제거Removing plaque, whitening effect, removing bad breath 가글용 민트향Mint for gaggle incense 0.200.20 식용 착향제Edible flavoring agent 시트러스Citrus 0.100.10 천연 식용보존제Natural edible preservative 올리브 유화왁스Olive oil wax 0.300.30 천연 유화제Natural emulsifier 효소처리스테비아Enzyme treatment Stevia 0.0500.050 감미제Sweetener 자일리톨Xylitol 0.10~0.500.10 to 0.50 정제수Purified water To 100To 100

3. 의치세정제의 조성물3. Composition of denture cleanser

원료명Raw material name 함량(content( 중량%weight% )) 배합목적Purpose of blending 동백잎 추출물Camellia leaf extract 0.001~0.0500.001 to 0.050 주 효능성분(치은염, 구강유해균 억제, 항산화활성, 구취개선, 치통 및 잇몸궤양 및 구강질환 개선, 항염) Main active ingredients (gingivitis, inhibition of oral bacteria, antioxidant activity, improvement of bad breath, improvement of toothache and gingival ulcer and oral disease, anti-inflammation) 배초향 정유Refined oil 1.00~2.001.00 to 2.00 산수유 추출물Corn oil extract 0.001~0.0500.001 to 0.050 인동초 추출물Ginseng extract 0.001~0.0500.001 to 0.050 상엽 추출물Leaf extract 0.001~0.0500.001 to 0.050 클로르헥시딘(Chlorhexidine)Chlorhexidine 1.00~2.001.00 to 2.00 소독제disinfectant 폴리소베이트 20(Polysorbate 20)Polysorbate 20 (Polysorbate 20) 0.30~1.000.30 to 1.00 유화제, 산포제Emulsifier, dispersant D-소르비톨액D-sorbitol solution 40~6040 to 60 습윤제Wetting agent 가글용 민트향Mint for gaggle incense 0.200.20 식용 착향제Edible flavoring agent 자몽씨 추출물Grapefruit seed extract 0.200.20 천연 보존제Natural preservative 정제수Purified water To 100To 100

폴리소베이트 20(Polysorbate 20)은 폴리소베이트 20은 소비톨 또는 소비톨의 1 또는 2무수물 각 1M에 대해 에틸렌옥사이드 약 20M과 축합한 소비톨과 소비톨무수물의 로르산과의 부분에스터 혼합물이다.Polysorbate 20 is polysorbate 20 is a partial ester mixture of sorbitol condensed with ethylene oxide at about 20 M and sorbitol anhydride, lauric acid for 1 M of 1 or 2 anhydrides of sorbitol or sorbitol.

4. 이쑤시게 코팅용 조성물4. Composition for toothpick coating

원료명Raw material name 함량(content( 중량%weight% )) 배합목적Purpose of blending 동백잎 추출물Camellia leaf extract 1.0~4.01.0 to 4.0 주 효능성분(치은염, 구강유해균 억제, 항산화활성, 구취개선, 치통 및 잇몸궤양 및 구강질환 개선, 항염) Main active ingredients (gingivitis, inhibition of oral bacteria, antioxidant activity, improvement of bad breath, improvement of toothache and gingival ulcer and oral disease, anti-inflammation) 배초향 정유Refined oil 0.001~0.0500.001 to 0.050 산수유 추출물Corn oil extract 0.001~0.0500.001 to 0.050 인동초 추출물Ginseng extract 0.001~0.0500.001 to 0.050 상엽 추출물Leaf extract 0.20~0.800.20 to 0.80 D-소르비톨액D-sorbitol solution 40~6040 to 60 습윤제Wetting agent 플루오르화나트륨
(불화나트륨)
Sodium fluoride
(Sodium fluoride)
0.220.22 충치예방Caries prevention
민트향Mint flavor 0.200.20 식용 착향제Edible flavoring agent 자몽씨 추출물Grapefruit seed extract 0.200.20 천연 보존제Natural preservative 정제수Purified water To 100To 100

5. 치실 코팅용 조성물5. Composition for dental floss coating

원료명Raw material name 함량(content( 중량%weight% )) 배합목적Purpose of blending 동백잎 추출물Camellia leaf extract 1.0~4.01.0 to 4.0 주 효능성분(치은염, 구강유해균 억제, 항산화활성, 구취개선, 치통 및 잇몸궤양 및 구강질환 개선, 항염) Main active ingredients (gingivitis, inhibition of oral bacteria, antioxidant activity, improvement of bad breath, improvement of toothache and gingival ulcer and oral disease, anti-inflammation) 배초향 정유Refined oil 0.001~0.0500.001 to 0.050 산수유 추출물Corn oil extract 0.001~0.0500.001 to 0.050 인동초 추출물Ginseng extract 0.001~0.0500.001 to 0.050 상엽 추출물Leaf extract 0.20~0.800.20 to 0.80 D-소르비톨액D-sorbitol solution 40~6040 to 60 습윤제Wetting agent 플루오르화나트륨
(불화나트륨)
Sodium fluoride
(Sodium fluoride)
0.220.22 충치예방Caries prevention
민트향Mint flavor 0.200.20 식용 착향제Edible flavoring agent 자몽씨 추출물Grapefruit seed extract 0.200.20 천연 보존제Natural preservative 식물성 글리세린Vegetable glycerin 5.005.00 습윤제Wetting agent 정제수Purified water To 100To 100

6. 구강용 필름 조성물(치아미백 필름 외)6. Oral film composition (other than tooth whitening film)

원료명Raw material name 함량(content( 중량%weight% )) 배합목적Purpose of blending 동백잎 추출물Camellia leaf extract 1.0~4.01.0 to 4.0 주 효능성분(치은염, 구강유해균 억제, 항산화활성, 구취개선, 치통 및 잇몸궤양 및 구강질환 개선, 항염) Main active ingredients (gingivitis, inhibition of oral bacteria, antioxidant activity, improvement of bad breath, improvement of toothache and gingival ulcer and oral disease, anti-inflammation) 배초향 정유Refined oil 0.001~0.0500.001 to 0.050 산수유 추출물Corn oil extract 0.001~0.0500.001 to 0.050 인동초 추출물Ginseng extract 0.001~0.0500.001 to 0.050 상엽 추출물Leaf extract 0.20~0.800.20 to 0.80 D-소르비톨액D-sorbitol solution 10~4010 to 40 습윤제Wetting agent 과산화수소(Hydrogen peroxide)Hydrogen peroxide 0.005~0.050.005 to 0.05 치아미백효과Tooth whitening effect 플루오르화나트륨
(불화나트륨)
Sodium fluoride
(Sodium fluoride)
0.220.22 충치예방Caries prevention
민트향(mint scent)Mint scent 0.200.20 식용 착향제Edible flavoring agent 자몽씨 추출물Grapefruit seed extract 0.200.20 천연 보존제Natural preservative 정제수Purified water To 100To 100

7. 잇몸 보호용 젤 조성물7. Gel composition for protecting gums

원료명Raw material name 함량(content( 중량%weight% )) 배합목적Purpose of blending 동백잎 추출물Camellia leaf extract 1.0~4.01.0 to 4.0 주 효능성분(치은염, 구강유해균 억제, 항산화활성, 구취개선, 치통 및 잇몸궤양 및 구강질환 개선, 항염) Main active ingredients (gingivitis, inhibition of oral bacteria, antioxidant activity, improvement of bad breath, improvement of toothache and gingival ulcer and oral disease, anti-inflammation) 배초향 정유Refined oil 0.001~0.0500.001 to 0.050 산수유 추출물Corn oil extract 0.001~0.0500.001 to 0.050 인동초 추출물Ginseng extract 0.001~0.0500.001 to 0.050 상엽 추출물Leaf extract 0.20~0.800.20 to 0.80 D-소르비톨액D-sorbitol solution 40~6040 to 60 습윤제Wetting agent 식물성 글리세린Vegetable glycerin 5.005.00 플루오르화나트륨
(불화나트륨)
Sodium fluoride
(Sodium fluoride)
0.220.22 충치예방Caries prevention
민트향(mint scent)Mint scent 0.200.20 식용 착향제Edible flavoring agent 자몽씨 추출물Grapefruit seed extract 0.200.20 천연 보존제Natural preservative 젤라틴gelatin 0.8~2.00.8 to 2.0 해조류 유래 젤Seaweed derived gel 정제수Purified water To 100To 100

본 발명에 의하면, 치약조성물과 동일하게 구강용 조성물에 치은염 개선, 항산화활성, 구강유해균의 억제 및 살균, 치석개선능을 주요 효능으로 가지고 있는 동백나무 잎으로부터 추출된 추출물과 배초향 정유(essential oil), 산수유 추출물, 인동초 추출물, 상엽 추출물을 첨가하므로서 이들 천연물을 함유한 조성물이 다양한 구강질환, 특히 치은염 및 치주질환 개선과 치료효과가 있음을 알 수 있다. According to the present invention, in the same manner as the dentifrice composition, an extract derived from camellia leaves and an essential oil, which have gingivitis improvement, antioxidative activity, inhibition and sterilization of oral pest bacteria, , Corn oil extract, ginseng extract, and mulberry leaf extract, it is understood that the composition containing these natural substances improves and treats various oral diseases, especially gingivitis and periodontal disease.

또한 본 발명에 의하면, 구강용 조성물은 조성물의 색상이 유지되고 향이 변화되더라도 치약에 함유된 약효제의 효과가 유지되고 사용 시 상쾌함을 주는 효과가 있다.In addition, according to the present invention, the composition for oral use has the effect of maintaining the effect of the pharmacologically active agent contained in the dentifrice even when the hue of the composition is maintained and the fragrance thereof is changed, and it is refreshing when used.

이상의 설명은 본 발명의 기술 사상을 예시적으로 설명한 것에 불과한 것으로서, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자라면 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 다양한 수정 및 변형이 가능할 것이다. 따라서, 본 발명에 개시된 실시예들은 본 발명의 기술 사상을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시예에 의하여 본 발명의 기술 사상의 범위가 한정되는 것은 아니다. 본 발명의 보호 범위는 아래의 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.The foregoing description is merely illustrative of the technical idea of the present invention, and various changes and modifications may be made by those skilled in the art without departing from the essential characteristics of the present invention. Therefore, the embodiments disclosed in the present invention are intended to illustrate rather than limit the scope of the present invention, and the scope of the technical idea of the present invention is not limited by these embodiments. The scope of protection of the present invention should be construed according to the following claims, and all technical ideas within the scope of equivalents should be construed as falling within the scope of the present invention.

Claims (12)

동백나무 잎으로부터 추출한 추출물 1~4중량%, 배초향 정유(essential oil) 0.001~0.010중량%, 산수유 추출물 0.001~0.010중량%, 인동초 추출물 0.001~0.010중량%, 상엽추출물 0.20~0.80중량%를 포함하는 구강용 조성물.Wherein the extract comprises 1 to 4% by weight of an extract from camellia leaves, 0.001 to 0.010% by weight of essential oil, 0.001 to 0.010% by weight of an extract of corn oil, 0.001 to 0.010% Oral composition. 제1항에 있어서,
상기 구강용 조성물은 치약 조성물 또는 세치제 조성물이며,
효소처리 스테비아 0.25~0.50중량%, 자일리톨 0.10~0.50중량%, D-소르비톨액 40~60중량%, 덴탈타입실리카 15중량%, 플루오르화나트륨 0.22중량%, 피리독신염산염 0.05중량%, 피로인산나트륨 0.50중량%, 식물성 글리세린 2~3중량%, 하이드록시 아파타이트 0.05중량%, 정제수 12.58~30중량%를 추가로 포함하는 구강용 조성물.
The method according to claim 1,
The oral composition is a dentifrice composition or a detersive composition,
0.1 to 0.50% by weight of xylitol, 40 to 60% by weight of D-sorbitol, 15% by weight of dental type silica, 0.22% by weight of sodium fluoride, 0.05% by weight of pyridoxine hydrochloride, 0.50% by weight of sodium pyrophosphate Wherein the composition further comprises 2 to 3% by weight of vegetable glycerin, 0.05% by weight of hydroxyapatite, and 12.58 to 30% by weight of purified water.
제1항에 있어서,
상기 구강용 조성물은 구강 청결제 또는 구강 세정제 조성물이며,
D-소르비톨액 40~60중량%, 식물성 글리세린 2.0~3.0중량%, 코코베타인 2.0~10.0중량%, 구연산(수화물) 0.005중량%, 플루오르화나트륨(불화나트륨) 0.22중량%, 민트향(mint scent) 0.20중량%, 자몽씨 추출물 0.20중량%, 효소처리스테비아 0.25~0.50중량%, 자일리톨 0.10~0.50중량%, 나머지 정제수를 추가로 포함하는 구강용 조성물.
The method according to claim 1,
The oral composition is an oral or oral cleanser composition,
(Sodium hydrosulfite) 0.22% by weight, citric acid (hydrate) 0.005% by weight, mint flavor (mint), sodium dodecylbenzenesulfonate 0.20% by weight of scent, 0.20% by weight of grapefruit seed extract, 0.25-0.50% by weight of enzyme-treated stevia, 0.10-0.50% by weight of xylitol, and remaining purified water.
제1항에 있어서,
상기 구강용 조성물은 구강향수 조성물이며,
D-소르비톨액 10.00중량%, 식물성 글리세린 2.0~3.0중량%, 코코넛오일 0.10중량%, 구연산(수화물) 0.005중량%, 민트향 0.20중량%, 시트러스 0.10중량%, 올리브 유화왁스 0.30중량%, 효소처리스테비아 0.050중량%, 자일리톨 0.10~0.50량%, 나머지 정제수를 추가로 포함하는 구강용 조성물.
The method according to claim 1,
The oral composition is an oral perfume composition,
D-sorbitol solution 10.00% by weight, vegetable glycerin 2.0-3.0% by weight, coconut oil 0.10% by weight, citric acid (hydrate) 0.005% by weight, mint flavor 0.20% by weight, citrus 0.10% by weight, olive oil wax 0.30% 0.065% stevia, 0.10-0.50% xylitol, and the remaining purified water.
제1항에 있어서,
상기 구강용 조성물은 의치세정제 조성물이며,
클로르헥시딘(Chlorhexidine) 1.00~2.00중량%, 폴리소베이트 20(Polysorbate 20) 0.30~1.00중량%, D-소르비톨액 40~60중량%, 민트향 0.20중량%, 자몽씨 추출물0.20중량%, 나머지 정제수를 추가로 포함하는 구강용 조성물.
The method according to claim 1,
The oral composition is a denture cleanser composition,
1.00 to 2.00 wt% of chlorhexidine, 0.30 to 1.00 wt% of Polysorbate 20, 40 to 60 wt% of D-sorbitol solution, 0.20 wt% of mint flavor, 0.20 wt% of grapefruit seed extract, Further comprising an oral composition.
제1항에 있어서,
상기 구강용 조성물은 이쑤시게 코팅용 조성물이며,
D-소르비톨액 40~60중량%, 플루오르화나트륨(불화나트륨)0.22중량%, 민트향 0.20중량%, 자몽씨 추출물0.20중량%, 나머지 정제수를 추가로 포함하는 구강용 조성물.
The method according to claim 1,
The oral composition is a composition for toothpicking,
The oral composition further comprising 40 to 60% by weight of a D-sorbitol solution, 0.22% by weight of sodium fluoride (sodium fluoride), 0.20% by weight of a mint flavor, 0.20% by weight of a grapefruit seed extract, and the remaining purified water.
제1항에 있어서,
상기 구강용 조성물은 치실 코팅용 조성물이며,
D-소르비톨액 40~60중량%, 플루오르화나트륨(불화나트륨) 0.22중량%, 민트향 0.20중량%, 자몽씨 추출물 0.20중량%, 식물성 글리세린 5.00중량%, 나머지 정제수를 추가로 포함하는 구강용 조성물.
The method according to claim 1,
The oral composition is a composition for dental coating,
The oral composition further comprising 40 to 60% by weight of D-sorbitol solution, 0.22% by weight of sodium fluoride (sodium fluoride), 0.20% by weight of mint flavor, 0.20% by weight of grapefruit seed extract, 5.00% by weight of vegetable glycerin, .
제1항에 있어서,
상기 구강용 조성물은 구강용 필름 또는 치아미백필름 조성물이며,
D-소르비톨액 10~40중량 %, 과산화수소(Hydrogen peroxide) 0.005~0.05중량%, 플루오르화나트륨(불화나트륨) 0.22중량%, 민트향 0.20중량%, 자몽씨 추출물 0.20중량%, 나머지 정제수를 추가로 포함하는 구강용 조성물.
The method according to claim 1,
The oral composition is an oral film or a tooth whitening film composition,
10 to 40 wt% of D-sorbitol solution, 0.005 to 0.05 wt% of hydrogen peroxide, 0.22 wt% of sodium fluoride (sodium fluoride), 0.20 wt% of mint flavor, 0.20 wt% of grapefruit seed extract, &Lt; / RTI &gt;
제1항에 있어서,
상기 구강용 조성물은 잇몸 보호용 젤 조성물이며,
D-소르비톨액 40~60중량%, 식물성 글리세린 5.00중량%, 플루오르화나트륨(불화나트륨) 0.22중량%, 민트향 0.20중량%, 자몽씨 추출물 0.20중량%, 젤라틴 0.8~2.0중량%, 나머지 정제수를 추가로 포함하는 구강용 조성물.
The method according to claim 1,
The oral composition is a gel composition for protecting the gums,
, 0.20% by weight of mint flavor, 0.20% by weight of grapefruit seed extract, 0.8% by 2.0% by weight of gelatin, and 40% by weight of D-sorbitol solution, vegetable glycerin 5.00%, sodium fluoride (sodium fluoride) Further comprising an oral composition.
제1항 내지 제9항 중 어느 한 항에 있어서,
상기 동백나무는 식물분류학적으로 동백나무속 동백나무(Camellia japonica L)인 구강용 조성물.
10. The method according to any one of claims 1 to 9,
Wherein the camellia is a Camellia japonica L plant taxonomically.
동백나무 잎으로부터 추출한 추출물 1~4중량%, 배초향 정유(essential oil) 0.001~0.010중량%, 산수유 추출물 0.001~0.010중량%, 인동초 추출물 0.001~0.010중량%, 상엽추출물 0.20~0.80중량%를 용제에 첨가하는 단계; 및
효소처리 스테비아 0.25~0.50중량%, 자일리톨 0.10~0.50중량%, D-소르비톨액 40~60중량%, 덴탈타입실리카 15중량%, 플루오르화나트륨 0.22중량%, 피리독신염산염 0.05중량%, 피로인산나트륨 0.50중량%, 식물성 글리세린 2~3중량%, 하이드록시 아파타이트 0.05중량%, 정제수 12.58~30중량%를 상기 용제에 첨가하는 단계를 포함하는, 구강용 조성물 제조방법.
0.001 to 0.010% by weight of an essential oil, 0.001 to 0.010% by weight of an extract of corn oil, 0.001 to 0.010% by weight of an extract of Rhizoctonia solids, and 0.20 to 0.80% ; And
0.1 to 0.50% by weight of xylitol, 40 to 60% by weight of D-sorbitol, 15% by weight of dental type silica, 0.22% by weight of sodium fluoride, 0.05% by weight of pyridoxine hydrochloride, 0.50% by weight of sodium pyrophosphate Adding 2 to 3% by weight of botanical glycerin, 0.05% by weight of hydroxyapatite, and 12.58 to 30% by weight of purified water to the solvent.
제11항에 있어서,
상기 동백나무는 식물분류학적으로 동백나무속 동백나무(Camellia japonica L)인 구강용 조성물 제조방법.
12. The method of claim 11,
Wherein the camellia is a Camellia japonica L (Camellia japonica L) plant taxonomically.
KR1020150010837A 2015-01-22 2015-01-22 Composition for mouth comprising camellia japonica l leaf extract and manufacturing method thereof KR101723588B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020150010837A KR101723588B1 (en) 2015-01-22 2015-01-22 Composition for mouth comprising camellia japonica l leaf extract and manufacturing method thereof
PCT/KR2016/000633 WO2016117933A1 (en) 2015-01-22 2016-01-21 Oral composition containing camellia leaf extract, and preparation method therefor
CN201680016936.0A CN107427454B (en) 2015-01-22 2016-01-21 Oral composition containing camellia leaf extract and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150010837A KR101723588B1 (en) 2015-01-22 2015-01-22 Composition for mouth comprising camellia japonica l leaf extract and manufacturing method thereof

Publications (2)

Publication Number Publication Date
KR20160090708A KR20160090708A (en) 2016-08-01
KR101723588B1 true KR101723588B1 (en) 2017-04-06

Family

ID=56417394

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150010837A KR101723588B1 (en) 2015-01-22 2015-01-22 Composition for mouth comprising camellia japonica l leaf extract and manufacturing method thereof

Country Status (3)

Country Link
KR (1) KR101723588B1 (en)
CN (1) CN107427454B (en)
WO (1) WO2016117933A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190094988A (en) * 2018-02-06 2019-08-14 주식회사 엘지생활건강 Composition for prevention or treatment of oral disease comprising Sunflower oil
KR102216388B1 (en) 2020-08-12 2021-02-17 전라남도 Composition for preventing, improving or treating cancer, including a pericarp extract of camellia
KR20210065576A (en) 2019-11-27 2021-06-04 전라남도 Composition for anticancer or cancer supplement comprising extracts of raw pericarp derived from immature fruit of Camellia japonica

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102337307B1 (en) 2017-04-10 2021-12-09 (주)아모레퍼시픽 Low irritating oral composition
KR102055667B1 (en) * 2018-01-19 2019-12-13 김한수 Toothpsate composites type gel tablet and that of manufacturing method
CN110384646A (en) * 2018-04-20 2019-10-29 毛怡 A kind of bletilla striata toothpaste and its preparation process
KR102209912B1 (en) * 2019-01-23 2021-02-01 김인 Mouthwash liquid composition containing matured crystal of hydroxy apatite
EP4110475A1 (en) * 2020-07-14 2023-01-04 Firmenich SA Reduction of undesirable taste notes in oral care products
KR102518501B1 (en) 2021-06-10 2023-04-04 영산대학교산학협력단 Antioxidant, anti-inflammatory and tooth whitening composition containing lemon extract and oral composition containing the same
KR102612967B1 (en) * 2023-06-26 2023-12-13 주식회사 고차원 Liquid compositions for oral use containing bifidus-ex

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0635376B2 (en) * 1985-02-27 1994-05-11 サンスタ−株式会社 Oral composition
KR930000059B1 (en) * 1990-04-24 1993-01-08 태평양화학 주식회사 Dental composition
KR940002170B1 (en) * 1991-06-05 1994-03-18 순흥화학공업 주식회사 Combat shoe
KR0138244B1 (en) * 1993-12-29 1998-05-15 최근선 Dentifrice compositions
US20060141039A1 (en) * 2004-12-23 2006-06-29 Colgate-Palmolive Company Oral compositions containing oxidized camellia
KR20100041922A (en) * 2008-10-15 2010-04-23 최정영 Mouthwash which include the chrysanthemum, germander and japonica extract
KR20120093607A (en) * 2011-02-15 2012-08-23 (주)한일제약 Oral liquid-type composition
CN102138887B (en) * 2011-04-06 2012-10-31 西南大学 Multifunctional compound rhizoma coptidis Chinese medicinal herb toothpaste
KR101506858B1 (en) * 2013-01-23 2015-03-30 (주) 베리콤 Herbal Extract for Having an Antibacterial and Antibiofilm Effect on Oral Pathogen
CN103735473A (en) * 2013-12-04 2014-04-23 何小刚 Herbal mouthwash and preparation method thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190094988A (en) * 2018-02-06 2019-08-14 주식회사 엘지생활건강 Composition for prevention or treatment of oral disease comprising Sunflower oil
KR102506599B1 (en) 2018-02-06 2023-03-06 주식회사 엘지생활건강 Composition for prevention or treatment of oral disease comprising Sunflower oil
KR20210065576A (en) 2019-11-27 2021-06-04 전라남도 Composition for anticancer or cancer supplement comprising extracts of raw pericarp derived from immature fruit of Camellia japonica
KR102297152B1 (en) 2019-11-27 2021-09-02 전라남도 Composition for anticancer or cancer supplement comprising extracts of raw pericarp derived from immature fruit of Camellia japonica
KR102216388B1 (en) 2020-08-12 2021-02-17 전라남도 Composition for preventing, improving or treating cancer, including a pericarp extract of camellia

Also Published As

Publication number Publication date
WO2016117933A1 (en) 2016-07-28
CN107427454B (en) 2020-07-17
CN107427454A (en) 2017-12-01
KR20160090708A (en) 2016-08-01

Similar Documents

Publication Publication Date Title
KR101723588B1 (en) Composition for mouth comprising camellia japonica l leaf extract and manufacturing method thereof
KR101841181B1 (en) Toothpaste composition comprising herval extract
JP2006199661A (en) Coaggregation inhibitor
KR20120093607A (en) Oral liquid-type composition
KR101743508B1 (en) Mouth cleaner comprising citrus or lime extract and manufacturing method thereof
KR101251161B1 (en) Composition of Toothpaste and Method of Preparing thereof
KR101778058B1 (en) Composition for sanitation promotion of oral cavity comprising natural medicinal ingredient extract as effective component for halitosis inducing microoranism and infectious disease of mucous membrane
KR102207872B1 (en) Oral composition for preventation or treatment of oral disease
JP2009263332A (en) Medicine containing olive leaf extract for maintaining health of periodontium
KR101068210B1 (en) The mixtures of extracts of Dryopteris crassirhizoma, pine needles and pomegranate for the inhibition of dental caries and periodontal diseases
KR101660467B1 (en) Oral composition containing fermentative extract of lycii fructus as active ingredient
KR101916377B1 (en) Composition for teeth whitening and preparation method therefor
KR20140031512A (en) Composition for treating oral disease and inhibiting halitosis comprising the extract of schizandra chinensis
KR101632910B1 (en) Mouth spray composition comprising cypress extracts and medical herb extracts and manufacturing method thereof
RU2312657C2 (en) Mouth cavity rinsing agent
KR20170142740A (en) Composition for treating or preventing oral diseases comprising natural complex
KR101613223B1 (en) Composition for mouth washing agent comprising cypress extract and cypress essential oil, and manufacturing method thereof
KR20220099175A (en) Oral composition comprising herbal complex
JP2022062913A (en) Oral care composition containing potato honey derived from sweet potato or supernatant of potato honey
KR102572961B1 (en) Compositions for preventing, improving or treating periodontal disease containing dendropanax morbifera lev. extracts
KR102632336B1 (en) Composition for prevention or treatment of dental disease comprising an extract of Daphne genkwa
KR20160068709A (en) Composition for toothpaste comprising cypress extract and manufacturing method thereof
KR102283663B1 (en) Antimicrobial composition comprising extracts of herb
Champaneri et al. Effectiveness of indigenously prepared Punica granatum and camellia sinesis mouthwashes as an adjunct to non surgical periodontal therapy: a clinical trial
KR102540804B1 (en) Composition containing Torreya nucifera extracts for preventing the formation of biofilm of mmicroorgaism

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right